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Abstract 
Early detection of genetic mutations is important for control of diseases such as 
cancer and Alzheimer’s.  Early detection requires methods that detect small amounts of 
mutated DNA in very large amounts of normal or wild type DNA.  One method to detect 
mutated DNA is the ligase detection reaction (LDR).  Since its inception, LDR has 
evolved greatly from a simple detection reaction after PCR amplification to 
PCR/RE/LDR, a scheme that uses nucleoside base analogs in PCR to convert wild type 
sequences to sequences containing restriction endonuclease (RE) sites which can then be 
cleaved leaving only mutant sequences for detection by LDR.  Analysis of LDR has also 
evolved from slab gel electrophoresis to microarray analysis. 
 Understanding the structure and DNA polymerase recognition of nucleoside base 
analogs used in PCR/RE/LDR is key to improving this detection scheme.  The use of 
higher fidelity DNA polymerase containing 3´→5´ exonuclease domains for error 
correction is also important in early detection of genetic diseases.  Pyrazole-based 
nucleoside analogs have been studied computationally and enzymatically.  The stability a 
DNA containing these analogs depends largely on the dipole moment of the analogs, 
rather than polarizability or surface area.  Reduced DNA polymerase recognition is due in 
part to altered base pair geometry, either inherent or created by DNA polymerase.  
Thiazole and thiazole N-oxide analogs to be used in the PCR/RE/LDR assay have been 
synthesized and characterized computationally, thermodynamically, and enzymatically.  
The N-oxide, a pyrimidine O2 mimic, enhances DNA stability and DNA polymerase 
recognition.  The N-oxide increases electrostatic properties and solvation by the 
formation of a hydrogen bond when base paired with guanine.  Enzymatic analysis 
 xx
indicated a preference for the base pairing of thiazole N-oxide with guanine and thiazole 
with adenine.  An N3´→P5´ phosphoramidate backbone analog has shown to inhibit the 
exonuclease activity of higher fidelity DNA polymerases for use in PCR/RE/LDR. 
 The evolution of the analysis of LDR continues with the adaptation to capillary 
and microdevice electrophoresis.  These formats were used to analyze model samples and 
LDR reactions mimicking low abundant mutations. These improved techniques greatly 
improve the resolution of LDR analysis.          
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Chapter 1:  Introduction 
 
 
1.1   Mutations 
 
Deoxyribonucleic acid or DNA carries the genetic information of the cell.1.1  This 
information is processed within the cell during replication and transcription.  During replication 
an enzyme, DNA polymerase, copies the information and during transcription an enzyme, RNA 
polymerase, transcribes the DNA into messenger ribonucleic acid, mRNA which is then further 
processed during translation into proteins which are the machines of the cell.  Transcription only 
occurs on portions of DNA that are genes.  The locations of transcription are governed by 
specific sequences termed promoters.  Portions of genes that are not transcribed are termed 
introns while transcription of DNA occurs on other portions of DNA termed exons.  The process, 
DNA ? RNA ? PROTEINS, is what governs the operation of most forms of life including 
humans.  The information of DNA is stored within a sequence which is made up of four 
nucleotides, each containing a different aromatic base:  adenine (A), thymine (T), guanine (G), 
and cytosine (C) (Figure 1.1).  Any error, or mutation, that occurs in the strings of nucleic acids 
may cause the above-described process to fail.  Therefore, the study and detection of mutations is 
very important to understanding the links between genetics and disease. 
Mutations are classified into many different categories based on the protein products 
formed after transcription and translation.1.2  Some mutations that occur can be silent.  During 
translation codons, groups of three bases, code for amino acids. If the amino acid that is encoded  
does not change, even though the codon sequence is changed, the mutation that occurred is 
termed a silent mutation.  For example, the codons CGC, CGA, and AGG are degenerate, they 
all code for arginine.  Therefore, if a mutation occurs forming any of these three codons arginine 
is still encoded and there is no change in the protein sequence that is synthesized.  Another 
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example of a silent mutation is one in which the mutation causes a change in a codon that 
changes the amino acid coded for yet the changed amino acid within the sequence of a protein 
does not change the function of the protein.  For instance, if the amino acid is on the outside of 
the protein and not contained within the active site the protein will still function normally. 
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PURINES PYRIMIDINES  
Figure 1.1.  The four natural bases found in DNA. 
 
The types of mutations that are not silent are classified into frameshift mutations and 
point mutations.1.2  Frameshift mutations occur when a portion of the DNA sequence is deleted 
or another sequence is inserted during replication or transcription.  These types of mutations lead 
to a complete change of codon sequences throughout the length of the exon, consequently 
frequently leading to a complete loss of protein synthesis.  Point mutations are characterized by 
the substitution of a single base for another at a specific location.  If a purine is substituted for 
another purine or a pyrimidine for another pyrimidine (e.g. A for G or T for C) this mutation is 
termed a transition.  If a pyrimidine is substituted for a purine or a purine for a pyrimidine (e.g. A 
for T or C for G) a transversion occurs. Point mutations are distinguished as either nonsense or 
missense in nature.  Nonsense mutations change a codon to a stop codon while missense 
mutations cause amino acid changes that change the function of a protein.   
Mutations that occur within the genome can be spontaneous or can be induced.  
Spontaneous mutations result from the natural process of the cells while induced mutations are 
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caused by the interaction of DNA with an outside agent or mutagen.1.2  The most important and 
frequent cause of spontaneous mutation is errant DNA replication.  If a DNA polymerase makes 
a “mistake” and inserts an incorrect base, and this base is not corrected, the mutation is then 
conserved throughout further rounds of replication and transcription therefore affecting the 
sequence of the mRNA produced and the protein synthesized. The rate of this type of mutation 
and the mechanisms of correction will be discussed later.  Spontaneous mutations are also seen 
during replication in locations within a DNA duplex that contain long “runs” or repeats of 
nucleotides.  The DNA polymerase tends to “slip” and therefore repeat many bases during 
replication consequently causing gene expansion.1.3,1.4  Spontaneous mutations can also be 
caused by natural structural alterations of the bases and by damage to the bases caused by 
metabolites of other cellular processes.1.2  One structural change that has been proposed to cause 
mutations is the tautomerization of the bases (Figure 1.2).  Guanine and thymine favor the keto 
form, but the enol form can occur.  Adenine and cytosine bases favor an amino form, but can 
exist in an imino form. These changes lead to different pairing trends among the bases.  For 
example, when guanine is in the enol form a G:T base pair is favorable rather the normal G:C 
base pair causing a point mutation.  Other structural changes that can occur include the 
deamination of cytosine to uracil (Figure 1.2), the oxidative deamination of adenine to 
hypoxanthine (Figure 1.2), and the alkylation of bases.  When cytosine is deaminated to uracil an 
A is coded for rather than a G.  Hypoxanthine encodes for C rather than the T encoded by 
adenine.  As a result deamination causes point mutations to occur within the genome.  Alkylation 
can also cause pairing aberrations, but can also cause spontaneous breakdown of the DNA 
molecule.  Free radical damage to DNA bases is a cause of spontaneous mutation that has  
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Figure 1.2.  Tautomerization of the natural bases and deamination of adenine and cytosine which 
lead to mutations. 
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received much attention.  Free radicals are produced as a result of oxidative metabolism and can 
oxidize the bases to cause mispairing. 
Natural or man-made chemicals that alter DNA bases are termed mutagens.1.2  Some 
DNA base analogs that mimic the DNA natural bases and are used in research and for other 
purposes can be mutagens by being incorporated into the DNA duplex during replication causing 
the formation of point mutations during the following rounds of replication or transcription.  
These types of base analogs include bromouracil and aminopurine.  Mutagens can also be 
chemicals that affect the structure of the natural bases therefore causing mispairing.  For 
example, nitrous acid causes the deamination of cytosine and adenine while methyl 
methanesulfonate and ethyl methanesulfonate are alkylating agents.  Intercalating dyes such as 
acridine orange, proflavin, and ethidium bromide are also mutagens due to their ability to insert 
between the bases of a DNA strand causing the DNA polymerase to insert an extra base across 
from the intercalating agent.1.1 
Ionizing radiation (X-rays and gamma rays) and ultraviolet (UV) light also cause 
mutations.1.2  Ionizing radiation is energetic enough to cause the formation of reactive ions when 
reacting with biological molecules.  This type of radiation also causes the formation of free 
radicals, formed from water molecules, and peroxide formed during cellular respiration that can 
then act as mutagens.  UV radiation is less energetic than ionizing radiation but the bases of 
DNA preferentially absorb these wavelengths.  The most common and most lethal mutations 
caused by UV radiation are the pyrimidine-pyrimidine dimers (Figure 1.3).1.2  These dimers are 
formed by the covalent attachment of pyrimidines in the same strand of DNA.  These dimers are 
very bulky therefore drastically changing the secondary structure of a DNA duplex causing the 
cessation of DNA replication and transcription completely. 
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Figure 1.3.  Formation of T-T dimer and T-C dimmer caused by UV irradiation and lead to 
mutations. 
 
While there are repair pathways for most of these mutations, not all are repaired and are 
therefore left to replicate.1.2  Mutations that are not repaired can then possibly lead to disease if 
they are located within the coding region of a gene.  Many diseases, such as diabetes, cancer, 
asthma, myocardial infarction, atherosclerosis, cystic fibrosis, Alzheimer’s and sickle cell 
anemia, are associated with genetic alterations in genomic DNA 
(www.ncbi.nlm.nih.gov/disease).   
1.2  PCR  
 
The polymerase chain reaction (PCR) has become the most widely used technique for 
DNA analysis and is thus the centerpiece of most mutation detection strategies.  PCR is used in 
most detection methods detecting mutations.  Most methods used are not sensitive enough to 
detect genomic DNA therefore sections containing mutations to be analyzed must be amplified 
by PCR prior to analysis.  The methods for mutation detection will be discussed later. 
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Figure 1.4.  Schematic representation of the polymerase chain reaction (PCR).  The first step 
includes denaturing of the double stranded DNA, followed by annealing of primers in the second 
step, and finally extension of the primers by DNA polymerase in the final step. 
 
 PCR was invented in 1983 by Dr. Kary B. Mullis for which he was awarded the Nobel 
Prize in Chemistry ten years later.1.5 The three steps of PCR which are cycled can be seen in 
Figure 1.4.  First, a double helical strand of DNA is separated or denatured with high 
temperature to form two single strands of DNA.  Secondly, primers, or shorter lengths of DNA, 
are annealed to the two longer strands or templates.  Two different primers are used to bracket 
the target sequence to be amplified.  One primer is complementary to one strand at the beginning 
of the target sequence while the second primer is complementary to the other strand at the end of 
the sequence.  Finally, a DNA polymerase enzyme and deoxyribonucleotide triphosphates 
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(dNTPs) extend the primers.  These three steps are repeated or cycled and the target sequence 
amplified exponentially.   
The DNA polymerase catalyzes the addition of the incoming deoxyribonucleotide 
triphosphate (dNTP) to the primer to form a phosphodiester linkage (Figure 1.5).   For PCR to 
work a thermostable polymerase must be used in order to withstand the high temperatures 
required for the amplification cycles.  Before PCR the DNA polymerases most widely used for 
research purposes were E. coli Polymerase I large fragment, otherwise known as Klenow 
fragment (Kf), and T7 DNA polymerase, which extend efficiently at 37 ºC.  The first 
thermostable DNA polymerase discovered was Thermus aquaticus (Taq).1.6-8 Since Taq many 
more thermostable polymerases have been discovered: Thermatoga maritima (Tma)1.9, 
Pyrococcus furiosus (Pfu)1.10-12, Thermus thermophilus (Tth)1.13,1.14, Pyrococcus species GB-D 
(Deep Vent)1.15, and Thermococcus litoralis (Tli or Vent).1.16  All of these enzymes have optimal 
activity at temperatures from 60 ºC-80 ºC, which makes them all useful in PCR.  One 
distinguishing characteristic is the presence or absence of an exonuclease domain.  The 
exonuclease domain of a polymerase allows correction or proofreading of extension mistakes or 
nucleoside mismatches.  This characteristic contributes highly to the fidelity or efficiency of the 
enzyme.  The existence of an exonuclease domain increases the fidelity therefore decreasing the 
number of mistakes that occur in the extension of a template. 
The DNA polymerase is the most significant element of PCR and DNA replication, as  
mentioned in Section 1.1.  The mechanism by which DNA polymerase replicates DNA is of 
utmost importance to understand the formation of most spontaneous mutations as well as to 
improve mutation detection methods as most rely on PCR. 
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Figure 1.5.  The nucleotidyl transfer mechanism catalyzed by DNA polymerase.  The atoms in 
red indicate the carboxylate triad (carboxylate groups of Asp and Glu residues) which position 
the Mg ions for chemistry to occur. 
 
 
1.3  DNA Polymerases 
DNA polymerases function in many ways within the cell.  By catalyzing the nucleophilic 
attack of the free 3´-hydroxyl of the primer on the phosphorus of the α-phosphate of the 
incoming dNTP it is able to function in DNA replication, repair, and recombination (Figure 1.5).  
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The many different polymerases within an organism differ slightly in structure yet share the 
aforementioned functions.  The known polymerases are classified according to structural 
differences, although all known polymerases are thought to have the same basic mechanism of 
action and similar overall structure, especially sharing the shape of the polymerase domain.  The 
family of polymerases of interest in this document is the Pol A or Pol I family, which includes 
bacterial polymerases such as E. coli Pol I, Taq, and bacteriophage T7 DNA polymerase.  Figure 
1.6 is the crystal structure of Taq polymerase with the different subdomains of the structure 
labeled.  The polymerase domain of such polymerases resembles an open right hand (Figure 1.6).  
The palm region is the subdomain that contains the active site.  The thumb and fingers 
subdomains flank the palm and contain regions which interact with the template and dNTP and 
binds duplex DNA upstream of the 3´ end of the primer strand, respectively.  
The DNA polymerase is an amazing “machine” when accomplishing template-directed 
polymerization of nucleic acids.  The polymerase must be able to chemically recognize and bind 
a primed DNA strand, recognize and bind a correct dNTP dictated by the template, catalyze a 
nucleotidyl transfer reaction, and reposition the newly extended primer for further cycles of 
nucleotidyl transfer.  The overall mechanism of DNA polymerase is seen below1.17-20: 
 
Pol       Pol·DNA   Pol·DNA·dNTP   Pol*·DNA·dNTP   Pol*·DNA+1·PPi    Pol·DNA+1·PPi    Pol·DNA+1+PPi   Pol·DNA+1 
 
Pol = DNA polymerase; Pol* = conformational change; PPi = pyrophosphate 
 
 
 
In the first step, the DNA polymerase binds the primed DNA template, which is then 
followed by binding of the dNTP.  The next step is a conformational change of the polymerase, 
which is the rate-limiting step because this is dependent on the correct dNTP being bound.  The 
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conformational change consists of the fingers subdomain moving in towards the palm subdomain 
forming a “closed” complex.1.21  This change can be seen in Figure 1.7.  Once the 
conformational change occurs the chemistry of nucleotidyl transfer occurs very quickly.  After 
transfer is complete, the conformation of the enzyme is returned to its original form, “open”, 
which is also a very slow step, followed by release of pyrophosphate and a repositioning of the 
DNA for further rounds of polymerization. 
 
 
 
 
 
Figure 1.6.  The conserved shape of all known DNA polymerases.  Adapted from the file 1JXE 
of the Protein Data Bank (PDB). 
 
  
 
Palm 
Fingers Thumb 
Exonuclease 
domain 
 12
When selecting the dNTP for incorporation, the polymerase binds dNTPs inbetween the 
fingers and thumb subdomains.1.21  The 3´-OH of the primer is held close to this junction 
forming a tight fit.  This restricted area limits the orientations of the incoming dNTP to certain 
geometries, ensuring that selection of the correct dNTP occurs through recognition of base pair 
geometry.  Once the correct dNTP is chosen, the closed conformation is formed, signaling 
nucleotidyl transferase chemistry to commence. 
The active site contains several acidic and polar amino acid residues as well as two metal 
cations (usually Mg+2) that position the components of the reaction.1.22  One metal ion binds the 
3´-OH of the primer and the α-phosphate of the incoming dNTP.  The positions are such that the 
pKa of the 3´-OH of the primer is lowered to favor the formation of a hydroxide anion to 
facilitate nucleophilic attack.  The second ion binds all of the phosphate groups of the dNTP 
helping in alignment so the reaction can proceed and for stabilization of the pyrophosphate 
product formed.   
 Processivity is a characteristic that varies among polymerases.1.23  Some polymerases 
perform many nucleotidyl transfer reactions per binding event, therefore making them much 
more processive than those that only perform one or a few.  Residues in the thumb subdomain 
make many contacts with duplex DNA blocking the DNA from completely dissociating from the 
Pol·DNA complex.  Therefore, the more contacts the greater the processivity of the polymerase. 
 If an incorrect dNTP is incorporated, the exonuclease domain is able to correct the 
mistake.1.24,1.25  Not all polymerases have an exonuclease domain, but those that do exhibit much 
higher fidelities.  The exonuclease domain can reduce the error rate of replication by 
approximately four orders of magnitude.1.2  The polymerase domain is approximately 30-40 Å  
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Figure 1.7.  Space filling models of Taq polymerase in the open complex (top) and the closed 
complex (bottom).  The cleft between the thumb and fingers decreases in size when the 
polymerase is ready to catalyze the nucleotidyl transfer reaction.  Images adapted from files 
2KTQ and 3KTQ of the Protein Data Bank (PDB). 
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away from the exonuclease domain: therefore, shuttling of the single stranded primer must take 
place for  exonucleolytic cleavage to occur.1.22,1.26  This happens when the fingers and thumb 
subdomains that contact the final base pair in the primer-template duplex sense distortions 
caused by mismatches.  This causes a stall in the change to a closed conformation, which gives 
the primer and template time to melt, or separate.  Then, the primer strand is transferred to the 
exonuclease domain where phosphodiester cleavage occurs through a  two metal ion mechanism 
similar to that described for polymerization only in reverse (Figure 1.8).  One metal ion is bound 
to the carboxylates of amino acid side chains and two oxygens of the phosphodiester linkage, one 
bridging oxygen, and one non-bridging oxygen.  The second metal ion is bound to carboxylates, 
the same non-bridging oxygen, and a hydroxide ion formed from a water molecule.  This 
hydroxide ion is in position for nucleophilic attack onto the phosphorous atom of the backbone.   
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Figure 1.8.  The cleavage mechanism used by the exonuclease domain of DNA polymerases.  
The pink atoms indicate the hydroxide ion formed for nucleophilic attack of the phosphate 
phosphorous.  The red atoms indicate the carboxylate oxygens of Asp and Glu residues located 
in the exonuclease active site. 
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1.4  Mutation Detection 
Identifying particular genetic mutation(s) is very important in order to utilize the benefits 
of presymptomatic diagnosis and to individualize the treatment.  For example, cancer is the 
second leading cause of death in the United States, comprising 23% of all deaths.  Many forms 
could be prevented with early detection of the genetic alterations that cause the disease, which 
are acquired early in the disease and can be conserved throughout its progression.  Detection of 
genetic predispositions to, for example, heart disease and cancer, would revolutionize clinical 
diagnosis and permit significant progress in preventative medicine.  Once the molecular basis of 
any disease is understood, analysis of the relevant genetic material requires robust tools to 
uncover its presence. Focus will be placed upon the detection of point mutations although some 
methods described can also be used for detecting frameshift mutations. An important problem in 
detecting point mutations is the occurrence of low abundant mutations or mutations that occur in 
low concentrations in the early development of a disease.  Techniques that are sensitive enough 
to detect low concentrations of mutations in very high concentrations of normal (wild type) DNA 
are a requirement for the early detection of disease. 
Point mutations that are associated with certain diseases may fall consistently in one 
position or several different positions along a large span of a gene.  For this reason two basic 
types of methods for mutation detection have been developed, scanning and diagnostic 
techniques.    Diagnostic methods are employed when the location of the mutation of interest is 
already characterized, while scanning or screening methods are used for an unknown location.  
While scanning methods potentially allow for the detection of all mutations in a specific region 
of DNA, the presence of the mutation(s) is the only information obtained and further analysis is 
required to obtain the specific genotype.  Diagnostic methods detect an already characterized 
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mutation and give the specific sequence composition of the mutation.  Although direct DNA 
sequencing (determining the primary structure of the DNA fragment under investigation) is the 
“gold standard” for diagnostics, the immense time and labor required to directly sequence DNA 
has lead to the development of alternative methodologies.  In addition, direct sequencing cannot 
determine the presence of low abundant mutations and is generally ineffective at analyzing 
heterozygous samples containing both normal and mutant DNA.  The detection of low abundant 
mutations has become a major goal of mutation detection for early detection of disease or the 
recurrence of disease.  A brief synopsis of some detection techniques follows. 
1.4.1  Scanning Methods 
One of the first scanning methods developed was restriction fragment length 
polymorphism (RFLP).1.27  RFLPs consists of fragments of DNA produced after restriction 
enzyme sites found in the target are cut by restriction endonucleases that recognize short 
sequences.  Point mutations, which must occur in the cutting site of the restriction endonuclease, 
change the pattern of fragments produced by these polymorphisms allowing separation and 
analysis via electrophoresis to uncover the presence of the mutation.  The technique is limited in 
that the mutation must occur at an existing restriction site or an additional restriction site must be 
created by the mutation.   
Many other scanning methods utilize the fact that changes in the properties of DNA occur 
when a mismatch is present in the duplex due to the presence of the mutation. These properties 
include modifications in electrophoretic mobilities and/or changes in duplex stability.  
Heteroduplex analysis (HDA) is a detection strategy that detects mutant DNA molecules by 
thermal denaturation and reannealing to form homo- and heteroduplexes of wild type and mutant 
alleles that have different electrophoretic mobilities due to bulges or thermodynamic instabilities 
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induced by mismatches.1.28,1.29 HDA can also be analyzed using denaturing high performance 
liquid chromatography (DHPLC).1.30  Denaturing gradient gel electrophoresis (DGGE)1.31, 
temperature gradient gel electrophoresis (TGGE)1.32, and constant denaturing gel electrophoresis 
(CDGE)1.33 are methods that enhance the unique electrophoretic mobilities of duplexed DNA 
containing mismatches through their reduced thermodynamic stability.  Single strand 
conformation polymorphism (SSCP) utilizes assay conditions, such as the addition of 
denaturants that are conducive to the formation of different secondary structures of single 
stranded DNA.1.34  Differing conformations of wild type and mutant DNA, which can be sorted 
by electrophoresis, exhibit sequence specific electrophoretic mobilities.  Figure 1.9 contains 
schematic representations of RFLP, HDA, and SSCP. 
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Figure 1.9.  Schematic representations of scanning methods. 
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1.4.2  Diagnostic Methods 
The majority of diagnostic techniques use, as a first step in the assay, amplification via 
the polymerase chain reaction (PCR).  PCR can be done either non-specifically, in which primers 
flank the coding region containing the mutation(s) or specifically, in which allele specific 
primers that hybridize to the mutation site are used in the PCR step.  If allele specific PCR is not 
used, the primary PCR reaction must be followed by another reaction that can discriminate 
between the wild type and mutant DNA.  A major concern associated with mutation diagnostic 
methods is the ability to detect low abundant mutations.  Diagnostic techniques must be sensitive 
enough to detect the mutant DNA without generating false positives or false negatives.  Figure 
1.10 contains schematic representations of the diagnostic methods described below. 
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PCR product is the indication of  the presence
of  mutant alleles.
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Fragments are formed after cleavage of  the mismatched heteroduplex.  
The presence of  smaller cleavage fragments indicates the presence of  
mutant alleles.
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The formation of  an extension product one base longer 
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Allele-Specific PCR
Enzymatic Cleavage
Minisequencing
 
Figure 1.10.  Schematic representations of diagnostic methods. 
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Allele specific PCR is accomplished with specially designed primers of defined lengths, 
which hybridize to the target at the mutation(s) potentially producing mismatches, with the 
premise being that mismatches in the primers impede or reduce the efficiency in the 
amplification step.  Two common techniques are PCR-RFLP and amplification refractory 
mutation system (ARMS).  In PCR-RFLP, only the mutant alleles are amplified by the addition 
of mismatches in the PCR primers before the restriction digests are performed.1.35  This allows 
much lower frequency mutations to be detected.  In ARMS, two amplification reactions are 
performed each with an amplifying primer specific for mutant or wild type DNA, thereby 
amplifying only one allele in each reaction for subsequent electrophoretic analysis.1.36 
There are also many enzymatic and chemical cleavage assays developed that are used for 
diagnostic analysis of mutations.  Different chemicals for each base (A, C, G, T) are used to 
cleave base mismatches formed when heteroduplexes are created.1.37,1.38  Enzymes such as 
bacteriophage T4 endonuclease VII1.39, T7 endonuclease I1.40, RNase A1.41, or Cleavase I1.42 
cleave mutant duplexed DNA according to changes in their secondary structure.  Cleavage 
fragments can then be analyzed by electrophoresis. MutS is also an enzyme that binds to 
mismatched DNA duplexes and the complex that forms is visualized with atomic force 
microscopy (AFM).1.43  
“Minisequencing” or single nucleotide primer extension is another detection method that 
has been used for detecting mutations.1.44  A primer is extended by only one nucleotide if the 3´ 
end is complementary to the target being analyzed.  The resultant fragments can be analyzed by 
electrophoresis, on DNA microarrays1.45,1.46, or using matrix assisted laser desorption ionization 
(MALDI) mass spectrometry.1.47,1.48  The sensitivity of this technique is limited by the efficiency 
of the DNA polymerase extending the primer. 
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Another family of diagnostic methods utilizes a DNA ligase enzyme.  A DNA ligase is an 
enzyme that will catalyze the formation of a phosphodiester bond preferentially in 
oligonucleotides hybridized to a target DNA strand.  DNA ligase has very high selectivity to 
“seal” DNA in which there is perfect complementarity (match).  A single base mismatch at the 
junction inhibits ligation.  The ligase detection reaction is one such diagnostic method (Figure 
1.11).1.49 LDR uses two adjacent primers and the thermostable ligase, Tth DNA ligase1.50-52, to 
distinguish all four bases potentially found at any position.  Two allele specific primers are used 
which differ in the base at their 3'-end.  This difference corresponds to the mutation difference of 
the gene.  A common primer, which is fluorescently labeled, is also used that is  
selective for the allele specific primer that hybridizes to the mutant sequence.  Since only the 
mutant discriminating primer ligates with the common primer this is all that is detected. 
In low level mutation detection of genetic diseases such as cancer, PCR/LDR detection 
reactions have been used to detect mutations with a sensitivity of 1 mutant in 4000 normal 
alleles.1.53  In order to increase this sensitivity a restriction endonuclease (RE) digestion step has 
been added in order to eliminate all normal or wild type alleles.1.54  A restriction endonuclease is 
an enzyme that catalyzes the hydrolysis of phosphodiester bonds in double helical DNA.  
Restriction endonucleases recognize specific sequences of four to eight base pairs and cleave 
very specifically the sequence recognized.  Therefore a specific sequence can be intentionally 
introduced into DNA and only these strands will be cleaved. 
Figure 1.12 shows an example of how this is accomplished with a detection strategy 
termed PCR/RE/LDR.  PCR/RFLP described above accomplishes the same goal but uses 
strategically placed mismatches in the PCR primer for conversion, yet mismatches that are read  
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Figure  1.11.  Schematic representation of the ligase detection reaction (LDR).  PCR products 
are denatured and common and discriminating primers annealed.  DNA ligase only ligates those 
duplexes which contain exact matches and thermocycling amplifies the amount of product 
formed linearly. 
 
 
 
 22
by DNA polymerases leading to errors in the further rounds of PCR, that lead to false positive 
results in analysis.  In PCR/RE/LDR nucleotide base analogs (indicated by Q in Figure 1.12) are 
used instead of mismatches.1.55  The analogs preferentially pair with one of the natural bases and 
therefore encode for that base specifically allowing for better conversion of the wild type 
sequence to one containing a restriction endonuclease recognition site.  As will be explained in 
Chapter 2, the Hammer research group synthesized many nucleoside base analogs for use in the 
PCR/RE/LDR detection strategy.  It was found that DNA polymerases tend to either “slip” when 
reading the analog or can flip out a base in the primer or template therefore extending the 
template by one less base.  Due to the aforementioned problems, detection limits of 
mutation:wild type sequences were not increased from the original PCR/LDR strategy.  It is the 
purpose of this document to discuss research performed in synthesizing new nucleoside analogs 
and in understanding the chemical factors that play a part in the mechanism by which the DNA 
polymerase extends a primer.   
The pyrazole based nucleoside analogs previously synthesized were analyzed 
computationally and in polymerase recognition assays to better understand the structural 
consequences of altering a nucleoside as well as the DNA polymerase reaction to the alterations.  
New nucleoside base analogs were designed in an attempt to explore direct hydrogen bonding 
contacts between DNA polymerase and the base opposite which a nucleoside triphosphate would 
be incorporated.  These analogs included a thiazole ring as the aromatic ring.  The addition of an 
N-oxide allowed probing of the importance of the O2 atom of pyrimidines to DNA replication. 
 A backbone modification, the N3´→P5´ phosphoramidate, was also synthesized and 
tested in DNA polymerase mediated DNA synthesis in order to inhibit the 3´→5´ exonuclease  
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Figure 1.12.  Diagram of the PCR step using nucleoside base analogs (Q) and the restriction 
endonuclease (RE)  step of PCR/RE/LDR.  PCR primers containing analogs are annealed to the 
DNA and extended.  Natural primers are then annealed and extended forcing DNA polymerase 
to incorporate a natural base across fromt the analog.  The incorporation forms a RE site which 
can then be cleaved leaving only mutant sequences to be detected by LDR. 
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activity of higher fidelity polymerases.  The inhibition of the exonuclease activity of these higher 
fidelity polymerases would allow for their use in PCR/RE/LDR without the excision of the 
nucleoside base analogs.  The use of higher fidelity polymerases is suggested to circumvent the 
problems associated with DNA polymerase slippage and flipping out of bases. 
A final evolution of LDR is associated with better electrophetic detection of products 
produced in the assay.  The original assay made use of slab gel electrophoresis.  Current methods 
of electrophoresis, such as capillary electrophoresis (CE) and microdevice electrophoresis 
increase the resolution of detection of DNA.  Application of these methods to PCR/LDR is the 
current step in making LDR practical for mutation detection. 
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Chapter 2:  Nucleoside Base Analogs 
 
 
 The mutation detection strategy PCR/RE/LDR depends on the use of nucleoside base 
analogs for conversion of natural sequences to restriction endonuclease recognition sites.  These 
analogs should preferably be equally stable in DNA as the natural bases and be replicated by 
DNA polymerases equally efficiently as natural bases.  In designing these analogs the factors 
contributing to DNA stability and DNA polymerase recognition need to be analyzed and 
understood for successful use in mutation detection strategies. 
2.1  Introduction 
 
Many chemical factors that affect DNA duplex stability and DNA polymerase 
recognition of DNA.  Nucleoside base analogs have contributed much to the understanding of 
these factors.  Base analogs have also been used to increase the degeneracy of the genetic code.  
Below are outlined the factors important to DNA duplex stability and recognition as well as a 
review of the literature concerning DNA nucleoside base analogs.   
2.1.1 DNA Structure and Stability   
DNA is composed of two strands of aromatic bases connected to a sugar-phosphate 
backbone (Figure 2.1).  The bases are nitrogenous heterocyclic rings and the backbone is 
composed of furanose rings connected by phosphodiester bonds.  The phosphodiester bonds have 
several preferred geometries, which leads to some limitation in sugar-phosphate backbone 
conformation.  The two strands are wound into a right-handed double helix to form a DNA 
molecule.    
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Figure 2.1.  The secondary structure of DNA indicating major and minor grooves on the left and 
helix width, pitch height, and distance between bases on the right. 
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The rings of the bases are connected to the sugar rings by a β-glycosidic linkage.  This 
bond is described by the torsion angle χ (Figure 2.2).2.1,2.2   The bases can be in either the syn or 
anti conformation with the anti conformation being such that the bulk of the base points away 
from the sugar and the syn with the bulk over the sugar ring.  The bases are planar due to the 
aromatic system of which the amino groups of cytosine and adenine are an integrated part.  The 
amino groups as well as other functional groups on the bases are hydrogen bond donors and 
acceptors.  Although the base rings are planar, the sugar ring exists in puckered conformations 
(Figure 2.3).2.1,2.2  It can be puckered in an envelope (C2´-endo or C2´-exo; C3´-endo or C3´-exo) or 
symmetrical (C2´-exo-C3´-endo) and unsymmetrical (major C3´-endo and minor C2´-exo) twist 
forms.  Although these are the major puckering modes puckering can occur intermediate to these 
modes and is defined by the pseudorotation angle, P.  DNA structure prefers the C2´-endo 
puckering mode (P = 137º to 194º) yet the syn/anti conformation dictated by the χ torsion angle 
can affect puckering mode.  The more syn the position of the base the more the C2´-endo 
puckering mode is favored.      
N
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N N
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NH2
O
OH
HOχ
anti syn  
Figure 2.2.  Syn and anti conformations of nucleosides. 
 
 
The bases pair with each other in a complementary fashion to stabilize the double helix:  
the pyrimidine C with the purine G (forming three hydrogen bonds) and the pyrmidine T with the 
purine A (forming two hydrogen bonds).  The two pyrimidine-purine base pairs form structures 
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similar in size and geometry (Figure 2.4).  The C1´- C1´ distance of each pair is approximately 11 
Å and the C1´-N bond angles are approximately 50º.2.3  It is the isostructural nature of the G-C 
and A-T base pairs that allow the folding of DNA.  In the helix the pitch is the distance along the 
helix required to complete one helix turn and the pitch height is the number of base pairs in this 
distance (Figure 2.1).  In B-form DNA the pitch is approximately 34 Å with a pitch height of 
approximately 10 base pairs.  The distance between a planar base pair and its neighbor is about 
3.4 Å. The double helix also forms grooves in the overall structure.  The minor groove, which is 
indicated by the O2 of pyrimidines and N3 of purines, has a width of 5.7 Å and a depth of 7.5 Å 
while the major groove is 11.7 Å wide and 8.5 Å deep.2.1,2.2   
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C2'-endo C3'-exo C2'-endo-C3'-exo
C2'-exo-C3'-endoC3'-endoC2'-exo  
Figure 2.3.  Sugar puckering modes of furanose rings in DNA.  The C2´-endo conformation is 
preferred in DNA. 
 
  The above-described structure of the DNA double helix is optimal for stability and there 
are many chemical factors that govern the structure and stability of the DNA molecule.  These 
factors (discussed below) can be measured by measuring the melting temperature (Tm) of the 
DNA double helix.  This is performed with optical thermal denaturation studies.2.4  Heating a 
solution of DNA causes the denaturation of the double helix into two single strands of 
polynucleotides.  In the case of highly cooperative transitions, once the temperature reaches the
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Figure 2.4.  A. Systematic numbering of bases; B. The positions of hydrogen bond donors and 
acceptors positioned in the grooves of DNA; C. The geometry of natural base pairs:  C1´-C1´ 
distances and C1´-N bond angles. 
 
 
 34
 Tm even a slight increase in temperature causes the forces holding the two strands together to 
cease and all of the hydrogen bonds between the base pairs are broken.  Therefore, the thermal 
denaturation of DNA can often be viewed as a simple two-state equilibrium (single stranded to   
duplex), which can be measured by UV absorbance.  Figure 2.5 shows an example of such a 
transition.  The UV absorbance of a DNA sample increases as the duplex is melted: therefore, the 
Tm is the temperature at which the UV absorbance is centered between the absorbance of double 
stranded DNA and the increased absorbance of single stranded DNA.  The more stable the DNA 
double helix, the higher the Tm.  From the Tm (and/or the melting curve) can be calculated 
thermodynamic properties by a van’t Hoff style analysis: 
H
SC
H
R
T
t
m ∆
∆+

•


∆= 4ln
1
     for non-self-complementary sequences, and  
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
∆= )ln(
1
     for self-complementary sequences, and  
Gibb’s free energy, ∆G, can then be calculated by: 
 
DNA duplex formation is driven by enthalpy rather than entropy.  The enthalpy term (∆H) is 
normally a large and negative while the entropy term (-T∆S) is almost as large a positive value 
making the free energy favorable.   
The enthalpy term is governed by the electrostatic properties that affect DNA duplex 
stability.  These properties include hydrogen bonding, base stacking, and the repulsion of 
negative charges of the two backbone phosphates.2.2,2.5  Hydrogen bonding has been defined; 
base stacking is the ability of the planar aromatic bases to π-stack with their neighboring bases in 
STHG ∆−∆=∆
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either a single or double stranded DNA molecule.  In double stranded DNA there is not only base 
stacking within the strand (intrastrand stacking) but bases also stack with bases in the 
complementary strand (interstrand stacking) due to the turn of the double helix.  Hydrogen 
bonding and repulsion of negative charges in the backbones enthalpically affect only the helical 
structure and not the single stranded DNA molecule, but base stacking is important enthalpically 
in both cases.   
 
Figure 2.5.  A typical transition in absorbance seen as temperature is increased causing all 
double stranded DNA to form single strands. 
 
The entropy term is governed by solvation and restriction of bond rotations.2.5  Due to the 
many electronegative atoms of the DNA molecule it is easily dissolved in water.  When the 
double helix is formed many of these atoms are unable to make hydrogen bonds with water 
because they are hydrogen bonding with other nucleosides: therefore, the process of solvation is 
more favorable entropically than formation of the double helix.  Another entropically 
unfavorable factor is the restricted rotation of bonds in the backbone.  When the helix is formed 
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these backbone torsion angles are stringently restricted as compared with that of a single 
stranded molecule.  This is also seen with the restriction of the χ angle when a duplex is formed. 
 Although hydrogen bonding within a duplex is unfavorable entropically the enthalpic 
gain from the formation of many hydrogen bonds between the bases largely makes up for the 
entropic loss.  The importance of hydrogen bonding to duplex stability will also be discussed 
later as this was studied using non-hydrogen bonding nucleoside analogs. 
 The electronic contributions that stabilize base stacking interactions in a DNA double 
helix include permanent dipoles, hydrophobic forces, dipole-induced dipole interactions (and 
therefore polarizability).2.2,2.5  The surface area of stacking also plays a role in base stacking.  It 
has been shown that the purines stack much more efficiently than the pyrimidines.2.6  This is due 
in part to the larger surface area of the purines as well as to hydrophobic forces, which dictate 
that it is more favorable for the planar aromatic surfaces of the bases to stack with each other 
than interact with water.   
2.1.2 DNA Polymerase Recognition  
Some of the above-mentioned contributions to DNA duplex stability may also play a role 
in DNA polymerase recognition of DNA and high fidelity replication.  DNA polymerases make 
specific hydrogen bonding contacts with DNA in the active site of the enzyme as well as making 
a stacking interaction (tyrosine residue) with the template base across from the incoming 
dNTP.2.7-10  Most of the hydrogen bonding contacts are between the negatively charged backbone 
and basic amino acid residues of the polymerase, but some of the bases are hydrogen bonded in 
the minor groove at O2 of pyrimidines and N3 of purines (Figure 2.4).  While the hydrogen 
bonds forming base pairs in the double stranded portion of the DNA do not seem to be 
recognized by the polymerase, when incorporating a dNTP there does seem to be formation of 
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hydrogen bonds between the last template base of the duplex and the incoming dNTP as well as 
normal stacking interactions with the last primer base.  Therefore, it can be said that hydrogen 
bonding and base stacking are important to correct nucleotide selection during replication. 
Restrictions to size recognition during DNA replication are also of importance.  Due to 
the tight fit of the incoming dNTP in the polymerase active site it is hypothesized that the shape 
of the base pair formed causes a steric restriction to inserting the correct dNTP.2.11,2.12  It has 
been hypothesized that the base pair, when the incoming dNTP is hydrogen bonding to its 
partner in the template, must be of the size of a natural Watson-Crick base pair. 
DNA polymerases convert the duplex DNA into A-form DNA in the active site.2.13,2.14  
The base pairs tend to show more A-character the closer to the point of insertion.  This is seen in 
crystal structures by analyzing the widening of the minor groove.  In A-form DNA the minor 
groove is wider than in B-form DNA.  This widening in the active site may be due to hydrogen 
bonding contacts between the thumb subdomain and backbone atoms in the minor groove.  In A-
form DNA the distance between base pair faces is 2.6 Å as compared to 3.4 Å in B form DNA.2.2  
This closer interaction in the active site may lead to an amplification of base stacking 
interactions. 
2.1.3 Nucleoside Base Analogs-The Literature  
Nucleoside base analogs have been used to test the import of the above mentioned factors 
to DNA duplex stability and DNA recognition by DNA polymerase.  As well as base analogs 
that occur naturally, there are different classes of novel analogs that have been synthesized and 
analyzed via thermal denaturation studies and DNA polymerase extension assays.  Figure 2.6 
shows the structures of all of the analogs discussed herein.  The first analogs to be studied were 
abasic sites in which the carbon-nitrogen glycosidic bond is hydrolyzed and no base is present, 
 38
and a nucleoside where the base is replaced with a phenyl ring. There is a large number of 
analogs that modify the natural bases altering hydrogen bonding and base stacking interactions 
as well as non-hydrogen bonding analogs that probe the importance of hydrogen bonds.  A 
number of analogs were also designed as universal base analogs that would pair to all four of the 
natural bases with similar efficiency.  A final class of analogs is azole based base analogs, which 
have also been used as univeral base analogs. 
2.1.3.1 DNA Stability 
The abasic site and phenyl ring, when incorporated into DNA, were found to be very 
destabilizing to the duplex due to the lack of hydrogen bonds and base stacking in the case of the 
abasic site and hydrogen bonds alone in the case of the phenyl ring.2.15,2.16  The abasic site 
destabilized the duplex by almost 16 ºC on average compared to the control sequence while the 
phenyl ring was almost 15 ºC destabilizing on average.  These examples started the probes of 
DNA duplex stability and have become standards by which destabilization is measured.  
Examples of purines being modified are that of O6 methylguanine2.17 and N6 
methoxyadenine2.18.  Both of these analogs were found to destabilize the duplex.  Another 
adenine analog in which the ring nitrogen at the 3-position is replaced with a carbon has also 
been synthesized has been found to destabilize the duplex by only 1 ºC.2.19  A pyrimidine 
modification includes an analog of thymine that lacks the O2 keto group which has been 
synthesized and tested by thermal denaturation.2.19  This analog was found to only destabilize the 
duplex by 1 ºC. The above two modifications of adenine and thymine lack the minor groove 
binding atoms and were found to induce a change from B-form DNA to A-form DNA due to a 
lack of the spine of hydrations which has been thought to be most important for DNA duplex 
stability in water.2.20,2.21  Modifications of pyrimidines have also included removing the 4-keto 
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and 4-amino group of thymine and cytosine, respectively.2.22   Both of these modifications are 
incredibly destabilizing to a DNA duplex to the point that in the thermal denaturation studies of 
the thymine mimic no random coil to helix transition was seen.  There has been much more 
attention placed on the modification of pyrimidines at the 5-position since the discovery that the 
addition of a methyl group to the 5-position of cytosine greatly stabilizes a DNA-DNA and 
DNA-RNA duplex.2.23,2.24  Polarizability of the base was suggested to be the cause of increased 
stability: therefore, further modifications at the 5-position of pyrimidines have been made to 
increase this property.  A group of alkyl, alkenyl, and alkynyl substituents was tested.2.25  Alkyl 
groups larger than methyl at the 5-position of thymine were shown to destabilize a DNA duplex 
while alkyl substituents on cytosine were stabilizing.  The alkynyl groups propynyl, pentynyl, 
and hexynyl were stabilizing on thymine yet propynyl was destabilizing to cytosine.  There have 
also been 5-position substitutions of halogen atoms.  A series of thymine modifications were 
synthesized contained iodine, bromine, and fluorine.2.26  Bromine and fluorine modified 
thymines were stabilizing while iodine was only slightly destabilizing.  A thymine mimic was 
also synthesized with a propynyl substituent at the 5-position.2.27  It was found to add 
approximately 1.5 ºC stability to a DNA-RNA duplex.  A final series of 5-substituted 
pyrimidines containing a pyridine, thiazole, imidazole, and thiophene was synthesized.2.28  All of 
the listed substituents were found to be slightly stabilizing, especially thiazole, to a DNA-RNA 
duplex (+0.3 ºC, +1.7 ºC, +0.7 ºC, +0.4 ºC, respectively). 
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Other analogs that have been synthesized completely remove the hydrogen bonding 
capability of the nucleoside in order to probe the importance of base stacking.  These analogs 
include difluorotoluene, trimethylbenzene, and dimethylindole.2.11,2.29  These analogs were 
designed as steric mimics of thymine and adenine, but without hydrophilic oxygens or nitrogen 
containing groups.  All of these analogs destabilized a DNA duplex by almost 20 ºC despite their 
structural similarity to the natural bases.  It was determined that although stacking was 
maintained due to the lack of hydrogen bonds, base pair geometry was not preserved and caused 
destabilization.  It is probable that the destabilization was caused in part by the hydrophobic 
nature of the analogs although this is not certain due the lack of entropic data in the report.  
Universal base analogs differ from the already mentioned analogs in that they usually do 
not resemble the natural bases in any way.  One of the first of the universal analogs was 5-
nitroindole.2.30  It was found to be equally stable base paired with all of the natural bases and 
only slightly destabilizing (-5 ºC) to the duplex as a whole.  A group of isocarbostyril nucleoside 
analogs has been reported.2.31,2.32  These analogs are slightly destabilizing to the duplex but pair 
equally well with the four natural bases.  Another recent addition to the family of universal bases 
is a pyrrolopyrimidine nucleoside analog of adenine in which in the sugar is attached to the N8 
position of the base.2.33  This analog has been shown to be equally stable with each of the four 
natural bases and is as stabilizing to the duplex as an A-T base pair.  The base pairs formed have 
different geometries than the natural base pairs but two hydrogen bonds are formed between each 
of the pairs.  Further structural analysis of this analog is needed for a better understanding of the 
forces responsible for the stability this analog imparts.     
Another group of analogs that were designed as universal analogs are the azole based 
nucleosides.  These analogs are nitrogen containing five-membered rings which would decrease 
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stacking due to a decrease in size of the heterocycle but have added substituents to make up for 
this decrease.  3-nitropyrrole was the first of these nucleoside reported. 2.34 It was shown to 
equally pair with all four of the natural bases yet was found to destabilize the DNA duplex by 
approximately 10 ºC.  Experimental and computational structural analysis was performed and it 
was found that a 3-nitropyrrole base pair varied only slightly from the natural base pairs.  NMR 
analysis of a DNA duplex containing 3-nitropyrrole indicated that the bulkiness of the nitro 
group protruded into the major groove and was the main cause of duplex destabilization.2.35   
Another report compared the stability of 3-nitropyrrole with a number of other azole based 
nucleoside analogs.2.36  These included pyrazole, 4-nitropyrazole, 4-nitroimidazole and 5-
nitroindole as well as comparing all of these to an abasic site.  In increasing order the order of 
stability was found to be abasic site (∆G = -4.7 kcal/mol), pyrazole (∆G = -4.8 kcal/mol), 
nitropyrrole (∆G = -6.3 kcal/mol), 4-nitropyrazole (∆G = -6.5 kcal/mol), 4-nitroimidazole (∆G = 
-7.0 kcal/mol) and finally 5-nitroindole (∆G = -8.1 kcal/mol).  While the stability of 5-
nitroindole is due to increased stacking area, the stability due to 4-nitroimidazole is due to a 
hydrogen bond formed when the base is in the syn conformation.  When comparing the abasic 
site, pyrazole, and nitropyrazole it is seen that the enthalpy and entropy terms of pyrazole and 
nitropyrazole are consistently low in absolute value while when the abasic site is paired opposite 
adenine or cytosine these values are quite large.  This indicates that electrostatic effects and 
solvation play a larger role in stabilizing an abasic site.  Carboxamide groups were also added to 
azole rings in the hopes of developing bases capable of pairing with two or more of the natural 
bases termed universal bases.2.37  The carboxamide group was designed such that it could rotate 
and have different hydrogen bonding patterns to accommodate the four natural bases.2.38  
Thermodynamic analysis of pyrrole-3-carboxamide was very destabilizing to the duplex and 
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showed a preference for pairing with thymine.  It was reported that the pyrrole ring stacked less 
efficiently and the amide group of the carboxamide did not obtain the position necessary for 
hydrogen bonding to maintain base pair geometry.  It was also learned that there was an entropic 
price due to the restriction of rotation of the carboxamide when in the duplex and that if the base 
was in the anti conformation pointing the carboxamide into the major groove there was a 
distortion of base stacking. 
2.1.3.2 DNA Polymerase Recognition  
Few of the novel nucleoside analogs used to study DNA structure and stability have been 
used to study DNA polymerase mechanism and fidelity.  Most analogs used to study DNA 
polymerase recognition of DNA have been naturally occurring analogs that are formed through 
mutagenic pathways.   
Most mutations that occur in DNA change the structure of guanine.  N2-
methylguanine2.39, 8-methylguanine2.40, O6-methylguanine2.41, and N2-ethylguanine2.42 have all 
been used in polymerase assays in determining the chemical reasons for DNA polymerase 
mechanism and fidelity.  N2-methylguanine and N2-ethylguanine are formed by the reaction of 
guanine with aldehydes (formaldehyde and acetaldehyde, respectively).  It was found that N2-
methylguanine encodes cytosine (84%) and thymine (9.4%) in primer extension reactions with 
exonuclease deficient Klenow fragment of E.coli polymerase I, or Kf(exo-).  This was mirrored 
in the kinetic analysis which indicated that the incorporation of thymine is only 1.2 times less 
efficient than cytosine.  Therefore, in a small amount, G→A transition mutations are formed.  
With Kf(exo-) N2-ethylguanine coded for guanine (40%) and cytosine (39%) forming G→C 
transitions.  These assays indicated that the 2-position amino group is critical for polymerase 
fidelity.  8-methylguanine was found to encode cytosine and only in small quantities adenine and 
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guanine (approximately 1% of each).  This indicates that position 8 of guanine is not critical in 
correct dNTP incorporation by DNA polymerases.  O6-methylguanine was found to encode  
thymine 76% of the time although kinetic analysis indicated that the efficiency of formation of 
this base pair was very low compared to a natural guanine-cytosine base pair and the rate of 
formation was lower than that of a thymine-guanine mismatch.  The hydrogen bond formed with 
this keto group is of great importance to DNA polymerase fidelity.  When studying O6-
methylguanine a guanine analog lacking N3, 3-deazaguanine, was synthesized for 
comparison.2.7,2.41  The rate of incorporation of cytosine opposite 3-deazaguanine was reduced by 
170-fold with Kf(exo-) indicating that the hydrogen bond formed between N3 and an amino acid 
residue in the active site is of utmost importance for recognizing a correct base pair.  A reduced 
efficiency was also reported indicating that the rate of the formation of the closed conformation 
of the polymerase was decreased. 
The novel synthesized nucleoside base analogs used in polymerase assays include the 
isocarbostyril analogs.2.32,2.43  These analogs were found to encode for the natural bases with 
slightly similar efficiencies but with greatly reduced efficiencies compared with the natural 
bases.  The isocarbostyril analog containing a propynyl functionality was use as a triphosphate in 
extension reaction and was found to be inserted less efficiently than the natural bases.  Other 
base analogs synthesized as triphosphates include thymine and cytosine mimics that lack the O2 
to test minor groove recognition by DNA polymerase.2.44  It was reported that in extension 
reactions with Kf(exo-) and Taq polymerase activity was inhibited with increasing amounts of 
analog indicating the O2 of pyrimidines is necessary for base pair recognition during dNTP 
incorporation by DNA polymerases.  Both of these analogs were C-nucleosides in which a 
carbon-carbon bond rather than the natural carbon-nitrogen bond connects the base to the sugar.  
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It was shown with a psuedo-thymine analog, which is also a C-nucleoside, that DNA polymerase 
activity is not altered by this modification.2.45  Incorporation of adenine opposite pseudo-thymine 
was similar in efficiency to the incorporation of adenine opposite thymine.   
Much enzymatic analysis has been reported with the nonpolar, non-hydrogen bonding 
analogs difluorotoluene (thymine mimic), 4-methylbenzimidazole (adenine mimic lacking an N3 
minor groove hydrogen bond acceptor), and 9-methyl-1-H-imidazopyridine (adenine mimic 
containing N3).2.46-51  Difluorotoluene was used as a dNTP and incorporation efficiency opposite 
adenine was found to be very similar in efficiency to the natural adenine-thymine base pair and 
with difluorotoluene in the template dATP was inserted only 3-fold less efficiently than opposite 
thymine.  These findings indicate that geometry plays a crucial role in base pair recognition and 
formation by DNA polymerase.  In extension reactions with Kf(exo-) and Taq polymerases the 
three analogs were placed both in the primer and template strands in separate reactions.  It was 
found that extension was more efficient with the natural base in the primer strand as compared to 
the analogs in the primer strand indicating that critical contacts between residues in the active 
site and the last base pair of the duplex being replicated are more important in the primer strand 
than in the template strand during the extension step of replication (Figure 2.10).  It was also 
found that the adenine mimic lacking the minor groove hydrogen bond acceptor was replicated 
much less efficiently than the mimic containing the hydrogen bond acceptor.  This indicates that 
this location of contact is important to DNA polymerase processivity and fidelity. 
Enzymatic analysis was also performed with azole nucleobase analogs.  3-nitropyrrole, 
pyrrole-3-carboxamide, pyrazole-4-carboxamide, pyrazole-3-carboxamide, and imidazole-4-
carboxamide were all incorporated into PCR primers and used to generate PCR products which 
were sequenced to determine which bases were incorporated across from the analogs.2.52  It was 
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found that adenine was incorporated the most opposite 3-nitropyrrole and pyrazole-4-
carboxamide (75% and 63%, respectively).  Thymine was incorporated opposite pyrrole-3-
carboxamide and imidazole-4-carboxamide most often (65% and 77%, respectively).  Pyrazole-
3-carboxamide coded for cytosine 51% and thymine 45%.  It is interesting that the abasic site 
tested coded for adenine 92% and all of the azole analogs coded for adenine most except 
pyrazole-3-carboxamide.  The “A-rule”2.53-55 states that DNA polymerases tend to insert an 
adenine when the chemical rules of incorporation do not apply to an insertion situation.  The “A-
rule” is a possible explanation for the adenine incorporation preference.        
2.2   Pyrazole Based Analogs 
2.2.1  Introduction 
 In the Hammer research group a series of pyrazole based analogs have been synthesized, 
thermodynamically characterized, and incorporated into PCR primers for analysis of polymerase 
insertion opposite these analogs for use in the PCR/RE/LDR mutation detection reaction.2.56  
These analogs have substituents at the 4-position of the pyrazole ring that vary in size, polarity, 
and stacking ability.  These substituents include, in increasing order of stacking ability, iodo, 
nitro, propynyl, and thiazolyl (Figure 2.7).  The complete characterization of these analogs will 
contribute to the understanding of DNA stability and polymerase recognition which will 
ultimately be useful for mutation detection.   
It was reported that all of the pyrazole based analogs when incorporated into the self-
complementary Dickerson dodecamer (5´-CGCXAATTYGCG-3´) were most stabilizing to a 
DNA duplex when paired with adenine although they were all quite destabilizing (-11 ºC to –31 
ºC). 2.56 The stability of the duplex increased with increasing stacking ability:  iodo (∆G = -6.3 
ºC) < nitro (∆G = -6.8 ºC) = propynyl (∆G = -6.8 ºC) < thiazolyl (∆G = -7.9 ºC).  The measured 
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Figure 2.7.  Structures of pyrazole based analogs. 
 
thermodynamic values as reported earlier are seen in Table 2.1 and bar graphs comparing the 
stability of each of the analogs can be seen in Figure 2.8.  This decrease in stability was 
consistent with a decrease in enthalpy as well as entropy indicating that these analogs affect both 
solvation and steric interactions as well as electrostatic effects.  Solvation is affected by the 
increased hydrophobicity of the analogs.  The loss of groove hydration leads to the decreased 
stability of a 4-substituted pyrazole-adenine base pair.2.19  The loss of hydrogen bonding and 
stacking ability lead to the small enthalpy term.  The small 5-membered pyrazole ring lacks the 
stacking surface area of the natural bases. Although the enthalpy and entropy values are 
consistently lower than the control sequences the values do not decrease with decreasing 
stacking ability.  The trend for the decrease in thermodynamic values is:  Nitropyrazole < 
propynylpyrazole < iodopyrazole < thiazolylpyrazole.  It can be hypothesized that 
thiazolylpyrazole has the greatest enthalpy and entropy values due the increased size of the 
stacking surface and increased hydrophilicity of the thiazole ring compared to the other base 
analogs.  Iodopyrazole and propynylpyrazole show a greater increase in enthalpy and entropy 
than nitropyrazole possibly due to rearrangement.  As can be seen in Figure 2.9 if these analogs  
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Table 2.1.  Thermodynamic values obtained from thermal melting analysis of the Dickerson 
dodecamer (5´-CGCXAATTYGCG-3´).  PzI = iodopyrazole, PzN = nitropyrazole, PzP = 
propynylpyrazole, and PzT = thiazolylpyrazole.2.56 
XY ∆Tm(ºC)/sub. ∆H (kcal/mol) 
∆S 
(cal/K•mol) 
∆G 
(kcal/mol) 
(298K) 
∆∆G 
(kcal/mol) 
(298K) 
T-A  -69.5 -189.3 -13.1  
G-C  -87.7 -235.9 -17.4  
C-G  -69.1 -183.9 -14.3  
A-T  -80.9 -219.3 -15.5  
PzI-A -16.7 -39.0 -110.0 -6.3 -6.8 
PzI-C -31.1 -28.8 -87.7 -4.5 -12.9 
PzI-G -26.3 -26.8 -72.8 -5.1 -9.2 
PzI-T -24.1 -26.5 -70.4 -5.5 -10.0 
PzN-A -14.3 -31.9 -84.3 -6.8 -6.3 
PzN-C -23.5 -28.9 -76.6 -6.1 -11.3 
PzN-G -21.8 -41.6 -120.4 -5.7 -8.6 
PzN-T -21.2 -31.6 -85.8 -6.0 -9.5 
PzP-A -14.7 -35.8 -97.6 -6.8 -6.3 
PzP-C -25.8 -41.3 -121.2 -5.2 -12.2 
PzP-G -18.1 -43.0 -121.8 -6.7 -7.6 
PzP-T -23.1 -25.3 -65.6 -5.8 -9.7 
PzT-A -11.2 -47.6 -133.2 -7.9 -5.2 
PzT-C -21.5 -32.7 -88.0 -6.5 -10.9 
PzT-G -13.0 -42.9 -116.7 -8.2 -6.1 
PzT-T -17.0 -33.8 -90.3 -6.9 -8.6 
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Figure 2.8.  Graphical representation of the stabilities of each of the pyrazole analogs reported 
earlier.  All of the analogs are most stable when base paired with adenine (top) and of the 
analogs thiazolylpyrazole is the most stable when paired with all of the natural bases (bottom). 
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occur in the anti conformation the propynyl and iodo substituents can stick into the major groove 
relieving some steric stress of the duplex.  Nitropyrazole is unable to relieve this stress in the 
same way due to the favored conformation in Figure 2.8.  Therefore, although the stabilities of 
nitropyrazole and propynylpyrazole are the same these analogs accomplish this in different ways.  
More structural characterization is required to analyze the thermodynamic values fully. 
 Nitropyrazole and thiazolylpyrazole were also incorporated into PCR primers and used in 
PCR reactions.  The resultant PCR products were sequenced to determine the incorporated bases 
opposite the analogs.  It was found that with Taq polymerase nitropyrazole coded for adenine 
94% of the time, and thiazolylpyrazole coded for adenine 93% of the time.  This agrees with the 
thermodynamic data that these two analogs are most stable when paired with adenine.  This is 
again probably due to the base pair geometry formed with adenine (Figure 2.8).  Cytosine is the 
only other base that these interactions are possible with, but the small size of the pyrazole ring 
would increase the C1´-C1´ distance too much. 
In order to affirm the above theories about pyrazole analogs, structural computational 
analysis of the factors leading to duplex stability were calculated and compared to the 
thermodynamic data.  DNA polymerase extension reactions were also performed with 
nitropyrazole and thiazolylpyrazole in order to understand further a stall product seen in the PCR 
product analysis and understand better the mechanism by which DNA polymerase chooses a 
dNTP to insert opposite the pyrazole analogs.  
2.2.2  Synthesis 
The synthesis of the pyrazole analogs was reported elsewhere.2.56  The reported synthesis 
is outlined in Scheme 2.1.  The p-toluoyl protected furanose ring was used to form the 1-chloro-
2-deoxy-3,5-di-O-tolouoyl-D-erythropentofuranose which was then reacted with the sodium salt  
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Figure 2.9.  The possible syn/anti conformations of the pyrazole analogs and probable base pair 
geometries formed with adenine.   
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of the iodopyrazole or nitropyrazole.  Palladium chemistry was used to convert iodopyrazole to 
propynylpyrazole and thiazolylpyrazole.  The synthesis of thiazolylpyrazole required the 
formation of trimethyltin pyrazole before Pd coupling with 2-bromothiazole.  The yield of the p-
toluoyl protected thiazolylpyrazole nucleoside was reported as being only 60%.  In an effort to 
increase yield and ease of synthesis a direct Pd catalyzed coupling of p-toluoyl protected 
iodopyrazole with thiazolyl zinc bromide was attempted (Scheme 2.2).  It was previously shown 
that biaryls could be formed by Pd catalyzed reactions of aryl-Zn derivatives with aryl 
halides.2.57,2.58  These reactions were found to proceed successfully with 5 mol% Pd catalyst.  
When the coupling of iodopyrazole and thiazolylzinc bromide was attempted 20 mol% Pd was 
required.  This led to problems with purification.  Due to the large excess of 
(tetrakis)triphenylphosphine palladium used, a large amount of triphenylphosphine oxide was 
formed, lowering the solubility of the final products.  The amount of triphenylphosine oxide 
formation could be reduced when the reaction was performed under an inert atmosphere (dry 
box).  Even though purification was greatly hindered a final yield of 90% was obtained.  The 
incorporation of these analogs into DNA oligonucleotides is illustrated in Scheme 2.3.  The 
synthesized analogs were p-toluoyl deprotected.  The 5´-hydroxyl was dimethoxytrityl protected 
and the 3´-hydroxyl was converted to a 2-cyanoethyl N,N-diisopropylphosphoramidite for use in 
the solid phase synthesis of oligonucleotides containing the analogs nitropyrazole and 
thiazolylpyrazole.2.56  
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2.2.3 Computational Analysis 
 Computational analysis of the nucleoside analogs was performed using the program 
Hyperchem 6.0 (Hypercube, Inc.).  Geometric optimization of the natural bases as well as the 
pyrazole analogs was performed with the AMBER and MM+ force fields.  While the RMS fit of 
the natural base database entries was lower with an AMBER minimization the RMS fit of the 
pyrazole analogs with the crystal structures obtained for the p-toluoyl protected nucleosides was 
lower with an MM+ minimization.  It was decided to continue analysis using the minimized 
structures from the MM+ geometrical optimization.  Semiempirical (PM3) calculations were 
then performed on the minimized structures of the natural bases as well as the pyrazole analogs.  
The values for surface area, dipole moment, and polarizability are shown in Table 2.2.  The RMS 
fit values for the natural bases are in comparison to the database values in Hyperchem 6.0 while 
those of the pyrazole analogs are in comparison to the crystal structures obtained as described 
above.   
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The values for surface area, dipole moment, and polarizability for the pyrazole analogs 
are within the range of the natural bases.  Thiazolylpyrazole was found to have the largest values 
of the properties computed.  Propynylpyrazole had a very large surface area, yet its dipole 
moment is comparable to that of iodopyrazole.  Nitropyrazole is smaller yet has a large dipole 
moment. 
In an attempt to correlate the calculated data with the thermodynamic data, plots of 
surface area, dipole moment, and polarizability versus -∆∆G37 ºC of the duplexes were made 
(Figures 2.10 and 2.11).  When each of the calculated parameters of the analogs is plotted versus  
-∆∆G values of each analog paired with the natural bases there is good correlation with dipole 
moment only.  Conversely, when the calculated values of the natural bases are plotted versus       
-∆∆G values good correlation is obtained with polarizability.  This indicates that the dipole 
moments of the analogs are inducing electrostatic interactions or polarization of the natural 
bases.  It is also seen that the surface area of the analogs shows intermediate correlation with 
stability.  Surface area tends to affect base pairing with purines more than with pyrimidines.  
This would seem to indicate that the major contributor to DNA duplex stability when a pyrazole 
analog is incorporated is due to electrostatic interactions.  It is also found that the three properties 
measured tend to show greatest correlation with stability when paired with the purines.  This is 
consistent with the thermodynamic data indicating that the analogs are most stable when base 
paired with adenine. 
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Table 2.2.  Semiempirical (PM3) computational analysis (MM+ minimization) comparing 
the natural bases and the pyrazole analogs. 
 
BASE 
 
RMS fit (Å) 
 
Surface Area 
(Å2) 
 
Dipole Moment 
(Debyes) 
 
Polarizability 
(Å3) 
Adenine 0.12 134.8 2.14 14.9 
Cytosine 0.05 118.8 5.92 10.9 
Guanine 0.07 142.9 7.02 14.2 
Thymine 0.06 134.3 4.11 11.9 
ANALOG     
Nitropyrazole 0.06 112.9 5.08 9.4 
Propynylpyrazole 0.05 134.4 2.52 12.0 
Iodopyrazole 0.06 118.6 2.57 12.6 
Thiazolylpyrazole 0.04 147.0 9.06 15.9 
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Figure 2.10.  Plots of -∆∆G values obtained from thermodynamic analysis versus calculated 
surface area and dipole moment values of pyrazole analogs.  
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-∆∆G vs. Polarizability
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-∆∆G vs. Polarizability (Natural Bases)
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Figure 2.11.  Plots of -∆∆G values obtained from thermodynamic analysis versus calculated 
polarizability value of the pyrazole analogs (top) and of the natural bases (bottom).  
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2.2.4 DNA Polymerase Recognition of Pyrazole Analogs 
DNA polymerase extension reactions were performed using oligonucleotide templates 
containing the pyrazole analogs nitropyrazole and thiazolylpyrazole.  Due to the evidence of 
shorter PCR products seen in the aforementioned PCR assays termination was hypothesized as a 
reason for these fragments.  It was thought that DNA polymerase was “stalling” when inserting 
dNTPs opposite the analogs (insertion step) and at the next base following the analogs (extension 
step).  (Figure 2.12)  Extension reactions were used to probe the site of termination and 
quantitate the amount of termination in hopes of learning more about DNA polymerase fidelity 
mechanisms. 
X
X
Y
X
YZ
DNA Polymerase
+
d TPY
DNA Polymerase
+
d TPZ
Primer
Template
Primer
Template
Primer
Template
INSERTION
EXTENSION
 
Figure 2.12.  The actions performed by DNA polymerase during template directed primer 
extension.  X represents the base in the primer.  X can be either a natural base or an analog.  Y 
and Z represent bases that are being added to the primer strand by DNA polymerase.  These 
bases can also be either natural or analog bases.  The DNA polymerase makes specific and 
separate contacts with X, Y, and Z during replication. 
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The sequences of primer (18nt) and template (25nt) used in the DNA polymerase 
extension reactions can be seen below. 
5´-CGC TCA ACT ATG TAA ACG 
3´-GCG AGT TGA TAC ATT TGC Q TAC TAG-5´ 
 
Q = thymine, nitropyrazole or thiazolylpyrazole 
 
The 5´-33P radiolabeled primer was extended directed by the templates containing thymine as 
well as the pyrazole analogs with Taq and Kf(exo-) polymerases.  The resultant extension 
products formed were then analyzed by electrophoresis.  The extension reactions can be seen in 
Figure 2.13.  The primer extended on the control template was fully extended after only one 
minute.  The primer extended on the nitropyrazole template did form full-length product even 
after one minute but termination product is still seen after 30 minutes.  With the thiazolyl 
pyrazole template less full-length extension product was seen than compared with either the 
control or nitropyrazole template.  There is slightly increasing amounts of termination product 
formed as time increases.  The major termination products seen with both the nitropyrazole and 
thiazolylpyrazole template correspond to the addition of a dNTP opposite the analog.  This 
indicates that a dNTP can be incorporated opposite the analog but that the polymerase then stalls 
when incorporating the next dNTP.  This indicates either an inability of the polymerase to form 
the closed complex or to form the phosphodiester bond.  This may be due to the change in the 
overall duplex structure, lack of hydrogen bonds positioning the analog in the active site, or a 
lack of stacking interactions with the tyrosine residue in the active site.  The change in overall 
duplex structure and lack of stacking interactions in the active site are less probable than the lack 
of hydrogen bonding interactions in incorporation of a dNTP opposite the analog since 
nitropyrazole was extended more efficiently than thiazolylpyrazole.  Thiazolylpyrazole was 
found to form a more thermodynamically stable duplex than nitropyrazole and the introduction 
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of the thiazole ring to the pyrazole ring increases stacking interactions more than nitropyrazole.  
The lack of minor groove hydrogen bonds to position the template base to be “read” by the 
polymerase would cause the wrong positioning of the template base, which would not allow the 
incoming dNTP to be in the correct position for nucleophilic attack by the 3´-hydroxyl of the 
primer.  In the extension step when binding of a dNTP to be inserted opposite the base to the 5´-
side of the analog, a change in the geometry of the analog-natural base (presumably adenine) 
base pair probably moves the 3´-hydroxyl of the primer out of position to perform nucleophilic 
attack.  In either case if the correct positioning is not attained a closed complex will not form and 
phosphodiester bond formation will not occur. 
 
 
Figure 2.13.  Extension assays of primers on templates containing thymine (control), 
nitropyrazole (PzN), and thiazolylpyrazole (PzT).  The primer is 18nt and the template is 
25nt in length.  Extension reactions were performed in 20 µL with 250 nM radiolabeled 
primer and template, and 200 µM solution of all four dNTPs, AmpliTaq® polymerase and 
the supplied buffer (100 mM Tris-HCl pH 8.3, 500 mM KCl).  An additional 8 mM MgCl2 
was added to the reaction. 
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The results indicate that nitropyrazole forms a base pair that more closely resembles the 
geometry of a natural base pair.  Although thiazolylpyrazole has more stacking ability and forms 
a more stable duplex structure than nitropyrazole the overall geometry of the base pair is 
distorted to such a degree that polymerization is almost impossible even after extended amounts 
of time.   
2.3 Thiazole and Thiazole N-oxide Analogs 
Thiazole and thiazole N-oxide base analogs were designed as pyrimidine mimics in order to 
probe the importance of the O2 minor groove hydrogen bond acceptor atom.  These analogs are 
modeled after the C-ribonucleoside tiazofurin, which has shown to be an antitumor agent.2.59,2.60  
Tiazofurin has a conformation such that the partially positive sulfur of the thiazole ring is 
energetically favored to be located over the partially negatively charged oxygen of the furanose 
ring.  This conformation allows the N-oxide to align in a DNA duplex in the same manner as the 
O2 of the pyrimidines.  Figure 2.14 compares the structures of tiazofurin, thiazole, and thiazole 
N-oxide.  Thiazole and thiazole N-oxide nucleoside analogs and oligonucleotides containing the 
analogs were synthesized.2.61 Computational, thermodynamic, and enzymatic analyses of thiazole 
and thiazole N-oxide and oligonucleotides were performed using the thiazole analog as a control 
in order to probe the effects of the N-oxide directly. 
 
O
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HO NS
O
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HO NS O
tiazofurin thiazole thiazole N-oxide
O
OHOH
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S
NH2
 
Figure 2.14.  Structures of tiazofurin, thiazole, and thiazole N-oxide base analogs. 
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2.3.1  Synthesis 
Many reports have provided synthetic details for preparation of the thiazole ring in 
tiazofurin and related analogs.2.62-64 The thiazole ring was constructed from ribofuranosylcyanide 
using the classical Hantzsch method, but with modifications to allow the preparation of 2-(2´-
deoxy-β-D-ribofuranosyl)thiazole and its N-oxide.2.65  The formation of the thiazole and thiazole 
N-oxide nucleoside analogs can be seen in Scheme 2.4.  Reaction of chlorosugar 1 with excess 
sodium cyanide in dry DME provided the nitrile 2 in a 3.2:1 β:α mixture of anomers in 83% 
yield.  As previously reported separation of these anomers proved difficult.2.62  Quantitative 
conversion of 2 to the thioamide by treatment with hydrogen sulfide and a catalytic amount of 
DMAP allowed ready purification of the β-anomer to provide compound 3.  The thioamide 3 
was refluxed with 50% aqueous chloroacetaldehyde in 2:1 THF:ethanol2.66, but the reaction was 
low-yielding (28%) and chromatographic separation of the thiazole nucleoside (4) from side-
products proved difficult.  However, reaction of 3 with bromoacetaldehyde diethyl acetal and a 
catalytic amount of 4 M HCl/dioxane in refluxing acetone2.67 provided compound 4 in improved 
yield (70%), with ready purification from side-products.   
For formation of the N-oxide (5), compound 4 was treated with 2 equiv of mCPBA2.68 in 
THF (72 h) to provide the N-oxide 5 in 48% yield.  Longer reaction times provided little 
additional product, although unreacted thiazole 4 was readily recycled.  However a more 
efficient method using 1.1 equivalents each of trifluoroacetic anhydride (TFAA) and hydrogen 
peroxide urea complex (UHP)2.69 was utilized, which provided a much higher yield (97%) after 
only 3 h at room temperature.  Removal of the hydroxyl protecting groups with NH4OH proved 
destructive to the thiazole ring of 4. Therefore, the esters of 4 and 5 were dissolved in 50 mM  
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Scheme 2.4.  Synthesis of thiazole and thiazole N-oxide analogs. 
 
 
 
sodium methoxide/methanol to provide the free nucleoside analogs 6 and 7 in 74% and 83% 
yields, respectively. 
The structure and absolute configuration of 4, 5 and 6 were confirmed by X-ray 
crystallography (Figure 2.15).  Structural analysis indicates a C2´ endo-sugar conformation (P = 
~180).  The thiazole ring is planar with the sulfur positioned over the oxygen of the furanose 
ring.  The dihedral angles, χ (O1´-C1´-C2-S1), for the toluoyl protected thiazole nucleoside, the 
toluoyl protected thiazole N-oxide nucleoside, and the free thiazole nucleoside are 21.6º, 23.0º, 
and 32.6º, which is comparable to other crystal structure data obtained for similar thiazole 
nucleosides.2.70 
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Figure 2.15.  ORTEP diagrams of p-toluoyl protected thiazole analog (A) and  p-toluoyl 
protected thiazole N-oxide analog (B). 
 
For incorporation into oligonucleotides, nucleoside analogs 6 and 7 were converted to 
their protected nucleoside phosphoramidites (Scheme 2.5).  The 5´-hydroxyl of each was 
dimethoxytritylated in anhydrous pyridine using 1.0 equiv of Et3N and dimethoxytrityl chloride 
(DMTCl) to provide DMT ethers 8 and 10 in 70% and 90% yield, respectively.  For complete 
conversion, compound 7 required treatment with a second equiv of Et3N and DMTCl. 
Phosphitylation of thiazole 8 was accomplished by treatment with 2-cyanoethyl 
tetraisopropylphosphorodiamidite (3 equiv), diisopropylamine (DIPA; 1 equiv) and tetrazole (1 
equiv) in dry CH2Cl2.  After a 2 h reaction time, CH3OH was added and the product purified to 
provide thiazole phosphoramidite 9 in 89% yield.  These conditions were initially used for the 
phosphitylation of thiazole N-oxide nucleoside 10 and resulted in a complex reaction mixture 
containing significant amounts of the deoxygenated thiazole amidite 9 as indicated by TLC. 
B. A. 
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Attempted phosphitylation of the N-oxide 10 with the more reactive chlorophoramidite reagent 
also led to a mixture of products containing mostly starting material as well as thiazole 
phorphoramidite 9.  Thus a modified protocol was developed whereby phosphordiamidite 
reagent is added portionwise to avoid large excesses.  To a solution of DMT-N-oxide 10 in 
CH2Cl2 was added DIPA (1.1 equiv), tetrazole (1.1 equiv), 2-cyanoethyl tetraisopropyl-
phosphorodiamidite (1.3 equiv) and was reacted for 30 min.  A second portion of 2-cyanoethyl 
tetraisopropylphosphorodiamidite (1.3 equiv) was added.  Following an additional 20 min of 
reaction, CH3OH was added to quench the reaction and thiazole N-oxide phosphoramidite 11 
was purified by flash chromatography in 67% yield. 
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Scheme 2.5.  Synthesis of thiazole and thiazole N-oxide phosphoramidites. 
 
For oligonucleotide synthesis, each nucleoside phosphoramidite was dissolved in dry 
acetonitrile to a 0.1 M concentration and used to prepare several self-complementary 
oligonucleotides based on the Dickerson dodecamer sequence, as well as oligonucleotides to 
examine the enzymatic properties of each analog (Section 2.3.4).  Due to the observed ammonia 
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lability of thiazole, phenoxyacetyl (Pac), 4-isopropylphenoxyacetyl and acetyl N-protection for 
dA, dG and dC phosphoramidites, respectively, were used for oligonucleotide assembly. (Glen 
Research, Sterling, VA)  The synthesis was performed on a 1.0 µmol scale, and all coupling 
steps except for the thiazole analogs were >98% by trityl assay. (vide infra)  Base and 
phosphodiester deprotection was accomplished using 50 mM potassium carbonate in methanol 
(200 µl) at room temperature for 3 h.  Acetic acid (1.5 eq.) in water (200 µl) was added and the 
resulting solutions evaporated to dryness. 
The deprotected oligonucleotides were analyzed by anion exchange HPLC.  Figure 2.16 
shows the resulting HPLC profile for the oligonucleotide sequence 5´-(CGCQAATTTGCG)-3´, 
where Q represents a nucleoside having either thiazole or thiazole N-oxide as heterocyclic base.  
Analysis of the products by MALDI spectroscopy indicates that the thiazole nucleoside is 
completely stable to the steps used for oligonucleotide synthesis and deprotection.  However, 
three product peaks are evident for the thiazole-N-oxide oligonucleotide.  The mass of the peaks 
corresponds to an octanucleotide (Figure 2.16 peak III) as well as intact dodecanucleotides 
containing either thiazole (Figure 2.16 peak I) or thiazole N-oxide (Figure 2.16 peak II).  The 
column used for anion exchange chromatography of the above dodecamer was not sufficient for 
separating the peaks of the larger 28-nucleotide sequence for enzymatic analysis : 5´-
ACTGQTCTCCCTATAGTGAGTCGTATTA-3´ where Q represents the position containing 
thiazole or thiazole N-oxide.  A quaternary ammonium functionalized polymeric anion exchange 
column was purchased from Dionex Corp.  The HPLC trace of the 28-nucleotide sequence 
containing thiazole N-oxide can be seen in Figure 2.17.   Five peaks were resolved in this 
analysis using 1 M NaCl, 25 mM NaOH (pH 12.4).  MALDI analysis was performed on each 
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peak and the first two peaks are of the mass of a 23-nucleotide sequence (calculated:  7005, 
measured:  7000), the third peak corresponds to the 28-nucleotide sequence containing thiazole  
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Figure 2.16.  HPLC trace of Dickerson dodecamer containing thiazole (A) and thiazole N-oxide 
(B).  HPLC was performed using a Hydrocell NS 1000 (anion-exchange) column (150 x 4.6 mm 
column) with Solvent A = 25 mM CHES pH 8, 30% methanol and Solvent B = 25 mM CHES, 1 
M (NH4)2SO4, pH 8, 30% methanol (0-100% B in 60 min with a flow rate = 1 mL/min). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17.  HPLC trace of the 28nt template containing thiazole N-oxide.  HPLC was 
performed using a DNAPac-100 (anion-exchange) column with Solvent A = 1 M NaCl, 25 mM 
NaOH (pH 12.4) and Solvent B = 25 mM NaOH (pH 12.4) (100-500 mM NaCl in 2 min, 500-
900 mM NaCl in 18 min, and 900-1000 mM NaCl in 3 min with a flow rate = 6 mL/min).   
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N-oxide (calculated:  8519, measured:  8513) and the fourth and fifth peaks correspond to a 28-
nucleotide sequence containing thiazole (calculated:  8504, measured:  8496).  
Both the problem in the synthesis of the thiazole N-oxide phosphoramidite 11 and the 
deoxygenation of thiazole N-oxide during solid phase oligonucleotide synthesis suggest that the 
activated P(III) reagents are causing the reduction.  A common method for reduction of aromatic 
N-oxides is the reaction with phosphorous trichloride.2.71,2.72  Thus, it appears that for 
deoxygenation to occur the N-oxide must first be covalently attached to the P(III) moiety.  In 
Scheme 2.6 a mechanism (A) is suggested whereby the thiazole N-oxide, whether resin bound or 
in solution reacts with activated phosphoramidite reagent to give a phosphitylated N-oxide 
species 12.  Once attached to the oxygen the phosphorous can donate its electrons to reduce the 
thiazole and create a metaphosphate-like intermediate.  This mechanism is favored over direct 
nucleophilic reduction by the P(III) reagents (B) as we find the thiazole N-oxide 
phosphoramidite to be stable to long term storage.  This explains the decreased coupling 
efficiency of the thiazole N-oxide phosphoramidite and therefore large peak corresponding to the 
octanucleotide seen in the HPLC chromatogram.  The tetrazole-activated N-oxide may be 
reacting with the phosphorous of other N-oxide phosphoramidite molecules, thus decreasing the 
concentration of the active phosphorous species. 
2.3.2  Computational Analysis 
 Computational analysis of thiazole and thiazole N-oxide nucleoside base analogs was 
carried out using Hyperchem 6.0 (Hypercube, Inc.).  The nucleosides were minimized using the 
AMBER force field since this force field is proven more correct for use with DNA and RNA and 
further molecular dynamics analysis of these analogs would warrant the use of this force field.  
Semiempirical (PM3) calculations were performed on the minimized structures and surface area,  
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Scheme 2.6.  Proposed mechanism for the deoxygenation of thiazole N-oxide containing 
oligonucleotides during DNA synthesis. 
 
 
 
 
 
Table 2.3.  Semiempirical (PM3) computational analysis of thiazole and thiazole N-oxide 
nucleoside analogs. 
 
BASES 
 
Surface Area (Å2) 
 
Polarizability (Å3) 
Dipole Moment 
(Debyes) 
Cytosine 
 120.7 10.9 6.58 
Thymine 
 134.5 11.9 4.28 
Thiazole 
 91.8 10.0 1.42 
Thiazole N-oxide 
 100.9 10.6 4.57 
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polarizability, and dipole moment values obtained.  The calculated values can be seen in Table 
2.3. 
While the thiazole analog falls terribly short of the pyrimidines in the value of each 
parameter, with the simple addition of the N-oxide the values of the calculated parameters 
become very close to those of the pyrimidines.  The charge of the N-oxide adds a great deal to 
the dipole moment.  In order to measure the charge difference between O2 atoms of cytosine and 
thymine compared with thiazole N-oxide partial atomic charges were calculated semiempirically 
(PM3) and the electrostatic potential mapped (Figure 2.18).  It is obvious that the charge of the 
N-oxide is much larger than that of the O2 of cytosine and thymine.  From the electrostatic 
potential maps (Figure 2.18) the direction of the dipole of thiazole N-oxide more closely mimics 
that of cytosine rather than thymine: therefore, a more favorable base pair should be expected 
with guanine.  A more favorable base pair with guanine is also expected when inspecting the 
hydrogen bonding patterns of the natural base pairs.  O2 of thymine does not form a hydrogen 
bond in an adenine-thymine base pair, but the O2 of cytosine does interact with the amino group 
of N2 of guanine. 
Preliminary Molecular Dynamics analysis of a Dickerson dodecamer containing a 
thiazole N-oxide-guanine base pair was performed.  The Molecular Dynamics structure of the 
Dickerson dodecamer with thiazole N-oxide incorporated can be seen in Figure 2.19 compared 
with the normal B-type Dickerson dodecamer.  The double helix is distorted slightly with the 
incorporation of the nucleoside analog.  Due to the thiazole ring and the amino group of guanine 
being moved out of the plane of the π stack the planarity of the base pairs directly above and 
below the thiazole N-oxide-guanine base pair are also distorted.  The distance between the 
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Figure 2.18.  Calculated partial atomic charges and electrostatic potential maps of cytosine, 
thymine, thiazole, and thiazole N-oxide.  In the electrostatic potential maps blue indicates a 
negative charge while red indicates a positive charge.  SYBYL MOPAC calculations at the PM3 
level were performed and the electrostatic potential was mapped onto a Connolly surface using 
these charges. 
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Figure 2.19.  Molecular Dynamics structures of the Dickerson dodecamer containing a cytosine-
guanine base pair at the arrow (A) and a thiazole N-oxide-guanine base pair at the arrow (B).  
Molecular Dynamics simulations were performed by ramping to 300 K or 400 K for 1 ps and 
then stepping down to zero.  These simulations used a 1 fs time step and constant pressure.  
SHAKE was used to constrain all hydrogens except those of the thiazole N-oxide-guanine base 
pair. 
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thiazole N-oxide-guanine base pair and the adenine-thymine base pair just below it is 3.9 Å, 
whereas this distance in the natural B-type DNA is 3.7 Å.  A double helix shape aberration is 
also evident in the measurement of the C1´-C1´ distances.  The C1´-C1´ distance of the cytosine-
guanine base pair is 10.73Å while this distance measures 11.20Å in the thiazole-N-oxide-guanine 
base pair.  An overall fit of the nucleotide monomers gives an RMS value of 1.72 showing that 
the double helix must change dramatically throughout the molecule to accommodate the thiazole 
N-oxide analog.  These distortions lead to an overall reduced stability of the double helix. 
 The cytosine-guanine and thiazole N-oxide-guanine base pairs were extracted from the 
aforementioned DNA molecules and are shown in Figure 2.20.   The first structural element that 
can be seen in these base pairs is the formation of a hydrogen bond between thiazole N-oxide and 
N1 of guanine rather than the expected N2 amino group.  The measurements of the hydrogen 
bond distances vary dramatically.  The hydrogen bond distance between the thiazole N-oxide and 
guanine is 2.56 Å, whereas the hydrogen bonds in the cytosine-guanine base pair measure 1.73 
Å, 1.83 Å, and 1.73 Å.  The longer length of the hydrogen bond formed between thiazole N-
oxide and guanine means that this noncovalent interaction imparts much less stability 
energetically to the base pair.  The increase in hydrogen bond length is due to the size of the 
thiazole ring.  The thiazole ring is much smaller than a cytosine ring which forces the sugar to 
base torsional angle to be strained.  It is apparent that although this analog perturbs the double 
helix, the hydrogen bond between the N-oxide oxygen and the hydrogen of N1 of guanine allows 
the two nucleotides to stay within close contact and allow the π system of the thiazole ring to 
base stack with the base pairs directly above and below it.  
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It has been shown through molecular modeling and Molecular Dynamics simulations that 
thiazole N-oxide pairs very strongly with guanine.  The hydrogen bond formed between these 
two bases is of utmost importance in the stability of DNA.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.20.  Cytosine-guanine (A) and thiazole N-oxide-guanine (B) base pairs extracted from 
the Molecular Dynamics structures in Figure 2.19. 
 
  
2.3.3 Thermodynamic Analysis 
Thermodynamic analysis was performed with thiazole and thiazole N-oxide incorporated 
into a Dickerson dodecamer seen below: 
5´-CGCQAATTYGCG-3´ 
3´-GCGYTTAAQCGC-5´ 
where Q = cytosine, thymine, thiazole or thiazole N-oxide and Y = adenine or guanine. 
 
 
A.
B.
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Table 2.4.  Thermodynamic properties of the Dickerson dodecamer (5´-
CGCQAATTYGCG-3´)containing thiazole and thiazole N-oxide nucleoside analogs. 
Q-Y Tm (100 µM) -∆Tm/sub. ∆H (kcal/mol) 
∆S 
(cal/K·mol) 
∆G37 ºC 
(kcal/mol) 
C-G 
 67.9 ---- -55.43 -144.16 -10.72 
T-A 
 67.1 ---- -79.92 -216.87 -12.65 
Z-G 
 16.5 -25.7 -53.18 -164.74 -2.08 
Z-A 
 11.5 -27.8 -35.79 -107.01 -2.60 
X-G 
 26.6 -20.7 -141.74 -442.97 -4.35 
X-A 
 <0 N/A N/A N/A N/A 
 
 
The experimentally determined Tm and thermodynamic properties of enthalpy, entropy, 
and free energy can be seen in Table 2.4.  Thiazole and thiazole N-oxide are very destabilizing to 
the duplex as can be seen from the value of -∆Tm/substitution.  The loss of stabilization of the 
duplex is due mainly to reduction of size of the thiazole heterocycle as compared to the 
pyrimidine ring of thymine and cytosine.2.11  The decreased surface area of the ring leads to a 
loss of intra- and especially interstrand base stacking which distorts the base stack and 
destabilizes the duplex.  A net increase of 11.4 ºC is seen with the addition of the N-oxide to the 
thiazole ring in the dodecamer due largely to the formation of a hydrogen bond between the N-
oxide oxygen and the N2 amino group or N1 of guanine (as indicated by molecular dynamics 
analysis).  As shown through computational analysis the large charge and dipole moment of the 
N-oxide allows hydrogen bonding with guanine.  This increase in stability is also due to the 
increase in solvation evident in the entropy increase of the duplex.  The hydrogen bonding and 
solvation of thiazole N-oxide allows for increased stability of the duplex over thiazole.  The melt 
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curve of the duplex containing a thiazole N-oxide-adenine base pair seems to show no duplex 
formation.  This is presumably caused by the inability of adenine to form a hydrogen bond with 
thiazole N-oxide.  Another possible reason for the lack of duplex formation is the ability of 
thiazole N-oxide to be highly solvated, which may possibly compete with the limited base 
stacking of the thiazole ring.  This allows no formation of a thiazole N-oxide-adenine base pair 
which in turn does not allow the formation of the duplex resulting in an uncooperative melt of 
the duplex.  
2.3.4  DNA Polymerase Recognition 
In order to test the importance of O2 of pyrimidines to DNA polymerase fidelity an 
extension assay was developed.  The sequences used are below: 
21nt primer:  5´-TAA TAC GAC TCA CTA TAG GGA 
23nt primer:  5´-TAA TAC GAC TCA CTA TAG GGA GA 
24G primer:  5´-TAA TAC GAC TCA CTA TAG GGA GAG 
24A primer:  5´-TAA TAC GAC TCA CTA TAG GGA GAA 
template:       3´-ATT ATG CTG AGT GAT ATC  CCT  CTQ GTC A-5´  
where Q = thymine in T-template, cytosine in C-template, 
thiazole in Z-template, or thiazole N-oxide in X-template. 
   
The above primers were designed to test many proposed premises about DNA replication by 
DNA polymerase.  The 21nt primer is three bases away from the analog in the template: 
therefore, the formation of the A-form DNA can occur before the polymerase encounters the 
analog.  It has been noted that the last three base pairs of a primer-template complex are in A-
form rather than the more usual B-form.  The question probed was whether polymerase 
efficiency is greater if this transition is allowed to occur before the interruption of the duplex by 
the analog.  The 23nt primer was designed so as to probe the insertion step (Figure 2.12).  The 
next dNTP to be incorporated is opposite the analog: therefore, direct minor groove contacts in 
the first single stranded base of the template strand can be explored.  The 24nt primers are 
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designed such that the extension step (Figure 2.12) can be investigated.  The final base pair in the 
primer-template complex is thought to contain many important minor groove contacts with the 
polymerase active site: an asparagine with the primer strand and a glutamine with the template 
strand.  The comparison of thiazole with no hydrogen bonding ability and thiazole N-oxide with 
considerable hydrogen bonding ability would explore these template contacts in the final base 
pair of the double stranded primer-template complex.   
 The 23nt primer was extended in the presence of all four dNTPs with Taq and Kf(exo-) 
DNA polymerases.  Additionally polymerase extensions were performed in the absence of dATP 
or dGTP in order to probe which base was inserted opposite the analogs more efficiently.  This 
was also investigated more quantitatively with kinetic single nucleotide insertion assays.  These 
assays were designed such that with the 23nt primer only one dNTP is offered to the DNA 
polymerase at varying concentrations yet keeping time as well enzyme and DNA concentrations 
constant.2.55  The percentage extension product formed can then be divided by the time (in 
minutes) to obtain the velocity of insertion for each dNTP concentration.  With this value a plot 
of dNTP concentration versus dNTP concentration divided by velocity can be obtained.  This 
plot is termed a Hanes-Woolf plot which is a linear plot of a Michaelis-Menten enzyme kinetics 
plot.  Michaelis-Menten kinetics is based on the following model: 
E + S      ES → E + P 
where E = enzyme, S = substrate, ES = an enzyme-substrate complex, and P = product formed. 
The Michaelis-Menten equation is: 
 




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From the Hanes-Woolf plot Vmax and Km values are attained.  The Km value is termed the 
Michaelis constant and is the concentration of substrate at which there is complete formation of 
the ES complex.  The Vmax value is a measure of the maximal velocity at which Km is reached.  
Vmax divided by Km then defines the efficiency of the enzyme.  These values have been obtained 
for single nucleotide extension of dATP and dGTP on the T, C, and Z templates.  
 The results of the extension reactions described above are seen in Figure 2.21.  These 
extensions were carried out with both Kf(exo-) and Taq polymerases.  When extending the 23nt 
primer, full extension is seen with both the natural base templates. Contrastingly the thiazole 
template gave only 45% extension with Taq polymerase and 68% extension with Kf(exo-).  The 
lack of full-length extension product is caused by the stalling of the polymerase at the addition of 
a dNTP when thiazole is in the final base pair of the primer-template duplex.  A dNTP is 
incorporated opposite thiazole such that there is a 40% stall product with Taq and 12% with 
Kf(exo-) formed at 24nt.  This indicates that Taq is much more restrictive when reading the final 
thiazole containing base pair and cannot as efficiently incorporate the next dNTP opposite the 
next base after thiazole in the template.  The thiazole N-oxide template gave only 22% full-
length extension product with Taq and 23% with Kf(exo-) and the stall product (24nt) is formed 
in 31% yield with Taq and 26% yield with Kf(exo-).  The main cause of loss of full-length 
extension product is the insertion of a dNTP opposite thiazole N-oxide.  While the loss of full-
length extension product with thiazole in the template can be attributed to incorporation of a 
dNTP opposite the next template base after thiazole, the loss of full-length extension product 
with the thiazole N-oxide template is due to the incorporation of a dNTP opposite the analog.  
This could possibly be due to the fact that with no hydrogen bonds made with the glutamine in 
the active site that the A-rule is adhered to whereas if a hydrogen bond is present there is a 
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continual search for a suitable dNTP that meets the other requirements for dNTP incorporation.    
Another possibility may be that there is simply more water molecules around the N-oxide which 
sterically inhibits a dNTP being placed opposite thiazole N-oxide. 
When extending the 23nt primer in the absence of dATP or dGTP it is evident that extension is 
much more efficient with the thiazole template when dATP is present and conversely, extension 
is more efficient with the thiazole N-oxide template when dGTP is present.  To further probe this 
the 24nt primers were extended.  Extension of the 24G primer with the thiazole template was less 
efficient than with the 24A primer, yet extension of the 24G primer with the thiazole N-oxide 
template was much more efficient than extension with the 24A primer.  The results of these 
assays possibly indicate that thiazole is encoding for adenine while thiazole N-oxide is encoding 
for guanine.  A possibility for the reduced extension product seen with extension of the 23nt 
primer on the thiazole N-oxide template may be that an adenine is being inserted as per the A-
rule when extension of the next base pair would be more efficient if a guanine was inserted.  
These hypotheses were further investigated with the kinetic analysis of single base insertion 
(vide infra).   
The final extension assay is extension of the 21nt primer.  With both polymerases 
assayed there is more product formed than with the 23nt primer.  This indicates that the 
polymerases may have much more ability to convert the modified sequence structure to A-form 
if the modification does not begin in the active site.  If the formation of A-form DNA does 
enhance the importance of stacking this explains the decreased amount of product compared with 
the natural sequences because the thiazole ring is much smaller: therefore, the area of stacking is 
much smaller. 
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Figure 2.21.  Extension reactions performed with templates containing thymine (T), cytosine 
(C), thiazole (Z), and thiazole N-oxide (X).  The percentages directly under the electrophoresis 
lanes correspond to the percentage of full-length product.  The percentage under the full-length 
product percentage is the percentage of stall product (24nt for the 23nt primer and 23nt for the 
21nt primer).  The third percentage in the case of the 21nt primer is the percentage of stall 
product formed at 24nt.  Extension reactions were performed in 20 µL with 200 nM radiolabeled 
primer and template, and 200 µM solution of all four dNTPs, polymerase and the supplied 
buffer. (Taq:  100 mM KCl, 100 mM (NH4)2SO4, 200 mM Tris-HCl, 20 mM MgSO4, 1% Triton 
X-100 pH 8.8).  An additional 8 mM MgCl2 was added to the reaction.  Kf(exo-):  100 mM Tris-
HCl pH 7.5, 5 mM MgCl2, 7.5 mM DTT.) 
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Results of the kinetic single base insertion reactions are seen in Table 2.5.  Insertion of 
adenine opposite thymine is almost 250-fold more efficient than insertion of guanine opposite 
adenine forming a thymine-guanine mismatch.  The formation of a cytosine-guanine base pair is 
more than 150-fold more efficient than the formation of a cytosine-adenine mispair.  The 
formation of a thiazole-adenine base pair is only 4-fold less efficient than formation of adenine-
thymine base pair and insertion of guanine opposite thiazole is 34-fold less efficient than the 
formation of a cytosine-guanine base pair.  It is interesting to note that the formation of base 
pairs containing thiazole is more efficient than the formation of mispairs.  This seems to 
contradict the extension reactions lacking dATP or dGTP and the extensions with the 24G and 
24A primers.  More full-length extension product is formed with the templates containing 
thymine or cytosine than those containing thiazole even though extension of the natural 
templates would require the formation of mismatches or already contain a mismatch at the 3´-end 
of the primer strand.  This can be explained by the values of Km and Vmax for thiazole.  The 
efficiency of the incorporation of adenine and guanine opposite thiazole is mainly gained from 
the velocity of base pair formation.  The Km value for adenine incorporation opposite thiazole is 
similar to that of a cytosine-adenine base pair while the Km for guanine incorporation opposite 
thiazole is much larger than any of the other values measured.  These values indicate that the 
polymerase must go through a lengthy trial and error process of binding many dNTPs before 
catalyzing the formation of the phosphodiester bond very quickly, especially in the case of a 
thiazole-adenine base pair.  Therefore, in the single nucleotide insertion reactions, where only 
one dNTP is available to the DNA polymerase, it is perceivable that the efficiency of a thiazole-
adenine or thiazole-guanine base pair would be greater than a natural mismatch but in the  
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 Table 2.5.  Kinetic parameters measured for single base insertion of dATP  
  or dGTP opposite thymine, cytosine, and thiazole. 
Template 
Base dNTP Km (µM) Vmax (%/min) 
Efficiency 
(Vmax/Km) 
T dATP  2.3(±0.7) 19.9(±0.9) 8.8 x 10
6 
 dGTP  85.7(±16.4) 3.1(±0.4) 3.6 x 10
4 
C dATP  25.8(±11.7) 5.2(±1.8) 2.0 x 10
4 
 dGTP  2.8(±0.3) 9.4(±0.6) 3.3 x 10
6 
Z dATP  20.1(±5.4) 42.0(±15.4) 2.1 x 10
6 
 
 
dGTP 
 150.0(±2.0) 14.6(±4.8) 9.7 x 10
4 
 
  
extension reactions when multiple dNTPs are available the polymerase may statistically be able 
to insert a more energetically stable base.                       
2.4 Conclusions 
By studying pyrazole based analogs and thiazole and thiazole N-oxide analogs much has 
been learned about designing new base analogs for the use in mutation detection strategies.  A 
lack of base pair geometry while not as important to DNA stability as electrostatic interactions 
and stacking area does seem to play a role in DNA polymerase recognition.  Therefore, when 
designing base analogs for mutation detection strategies more emphasis should be placed on base 
pair geometry (C1´-C1´ distances and C1´ bond angles).  Therefore, the size of the analog and 
accessible atoms for hydrogen bonding should be designed carefully.  From the analysis of 
thiazole and thiazole N-oxide the minor groove hydrogen bond sites are important for dNTP 
selection in DNA insertion and extension so these sites should be mimicked in designing analogs 
for mutation detection. 
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Chapter 3:  Nucleoside Backbone Analogs 
 
3.1  Introduction 
  
 In the point mutation detection assay PCR/RE/LDR, nucleoside analogs were shown to 
increase the efficiency of base conversion for the formation of restriction enzyme recognition 
sites, but the desired sensitivity of the assay was still not achieved.  This was due to the poor 
base pairing of the analog which causes “primer slippage” as well as the analogs may convert the 
base in question to multiple other bases which causes mismatches during PCR with the natural 
base primers after conversion.3.1  In other point mutation detection strategies, mismatches are 
strategically placed and must be retained to ensure that false positives are not generated.  To 
increase the sensitivity of the PCR/RE/LDR assay and other mutation detection strategies, higher 
fidelity DNA polymerases that have exonuclease (proofreading) activity must be used.  The use 
of backbone analogs would be a solution to the problem of removal of nucleoside analogs or 
strategically placed mismatches by the exonuclease domain of higher fidelity enzymes.  There 
are a number of backbone analogs which have been synthesized and proven resistant to 
nucleases.3.2,3.3  One such backbone modification is the N3´→ P5´ phosphoramidate in which 
nitrogen replaces the 3´-bridging oxygen of the phosphate backbone (3´-NHP(O)(O-)O-5´) 
(Figure 3.1). 
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Figure 3.1.  Structure of the phosphodiester (A), phosphorothioate (B), and phosphoramidate (C) 
backbone modifications. 
A. B. C. 
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3.1.1 Backbone Analogs-The Literature 
 Many of the nucleoside backbone analogs were synthesized and tested for nuclease 
resistance due the advent of their use in antisense and antigene technology which is currently 
being tested for its use in the treatment of diseases such as cancer, AIDS, and inflammation.3.4,3.5  
This new technology is based on the concept of inhibition of protein synthesis through the 
blockage of information transfer by binding oligonucleotides to either mRNA (antisense) or 
genomic DNA (antigene).  Backbone analogs have since been used in the study of DNA 
structure and function, and in site-directed mutagenesis.   
 The backbone analogs synthesized contain from a simple single atom replacement to 
complete replacement of the backbone such as in peptide nucleic acids (PNAs).3.2,3.3  PNAs are 
comprised of a peptide backbone with DNA bases attached at the α-carbon.  The most studied of 
the backbone analogs though are the phosphorothioates in which a non-bridging oxygen of the 
backbone phosphate is replaced by a sulfur atom3.6 (Figure 3.1).  This atom substitution changes 
the overall charge of the modified DNA molecule yet does not change the hybridization 
properties drastically.  Phosphorothioates were also found to inhibit the cleavage activity of 
nucleases.  The cleavage of a phosphorothioate containing oligonucleotide was found to be 
approximately ten times slower than the cleavage of a natural phosphodiester containing 
oligonucleotide using snake venom phosphodiesterase.3.7,3.8  The synthesis of phosphorothioates 
also leads to the formation of diastereomers, RP and SP, which adds an extra step of purification 
if they are to be used because most nucleases can degrade one or other of the diastereomers. For 
instance, snake venom phosphodiesterase was found to cleave only the RP isomer while 
nucleases S1 and P1 cleave only the SP isomer.3.9,3.10  Phosphorothioate linkages were also found 
to be resistant to the exonuclease activity of E. coli DNA polymerase I 3.11,3.12, but T4 DNA 
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polymerase cleaves these modified linkages at similar rates as the natural phosphodiester 
backbone.3.9  Due to this limited exonuclease resistance, phosphorothioate backbone 
modifications have only been used in site-directed mutagenesis experiments and PCR.3.13-17  It 
was found that the use of phosphorothioates did inhibit the exonuclease activity of higher fidelity 
enzymes yet the polymerase activity of the enzymes was decreased.  Further study of this 
modification by capillary electrophoresis found that a single 3´-modification afforded more 
exonucleolytic protection than multiple modifications.3.18 
 The N3´→ P5´ phosphoramidate backbone modification has been discussed as the second 
generation of antisense therapy due to its unique structural properties, increased hybridization, 
and increased nuclease resistance.  Oligonucleotides with every linkage replaced by a 
phosphoramidate modification have been studied intensely.  Circular dichroism (CD), Molecular 
Dynamics, NMR, and X-ray crystallography all indicate that these oligonucleotides exhibit a 
helical conformation more consistent with A-form DNA than the more natural B-form.3.19-22  
This is enough to explain the increased hybridization to mRNA as RNA displays an A-form 
conformation.  Further structural analysis indicates that this A-form conformation is adopted due 
the preferred C3´-endo furanose conformation.3.20  Increased hybridization can also been seen in 
the increased melting temperatures (Tm) of oligonucleotides containing phosphoramidate 
linkages.  These modifications were found to increase the Tm by as much as 27.5 ºC.3.19  Also 
indicated by structural analysis is the increased hydration of the grooves due to the more 
hydrogen bond donating character of the phosphoramidate as compared with the more hydrogen 
bond accepting character of the natural phosphodiester backbone.  The increased hydration 
causes a strong anomeric effect between the 3´-nitrogen lone pair and the antibonding orbital of 
the adjacent P-O5´ bond (Figure 3.2).  The phosphoramidate modification has also shown 
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increased nuclease resistance.3.23,3.24  A fully modified oligonucleotide resisted cleavage by snake 
venom phosphodiesterase a little more than an order of magnitude compared with the natural 
phosphodiester backbone (26 h compared with 20 min).  The only explanation for this resistance 
has been the anomeric effect stated above.        
 
NP
H
O
O
O
O
B
O
H
5'
3' Cl-  
Figure 3.2.  The anomeric effect caused by the addition of the 3´-nitrogen of the 
phosphoramidate modification.  The lone pair of the nitrogen interacts with the σ* antibonding 
orbital of the P-O5´ bond.  The structure is stabilized by the chlorine ion and the C3´-endo 
furanose conformation. 
 
 Due to the increased protection to nucleases afforded oligonucleotides by the N3´→ P5´ 
phosphoramidate backbone modification and the abovementioned finding that a single 3´-
phosphorothioate modification affords more protection than multiple modifications the 
phosphoramidate was proposed for use in point mutation detection strategies.  Also of interest 
was the structural finding that the phosphoramidate-modified oligonucleotides were of the A-
form conformation.  As stated in Chapter 2 the catalysis site of DNA polymerase converts the 
final few base pairs to A-form.  Due to the conformation of a primer-template duplex containing 
a 3´-phosphoramidate modification in the primer strand already being A-form the problem of 
decreased DNA polymerase fidelity found with phosphorothioate modified oligonucleotides 
would be circumvented.   
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3.1.2   Synthesis 
 
 N3´→ P5´ phosphoramidate backbone modification containing oligonucleotides have 
been synthesized in a number of ways.  One method was through chemical ligation in aqueous 
media.3.25  An amine-exchange procedure was also reported for the formation of a 
phosphoramidate linkage directly on a solid support.3.26,3.27  The 3´-aminonucleoside was 
attached to the solid support and was then reacted with the next phosphoramidite in the presence 
of tetrazole.  Another approach coupled preformed phosphoramidate dimers on a solid support.  
One method of dimer formation included the coupling of a phosphotriester with a 3´-
azidonucleoside in a Staudinger reaction forming an imine intermediate which is followed by a 
Michaelis-Arbuzov transformation enhanced by LiCl transforming the imine to an amide.3.28  
The resulting dimer product was then converted to a phosphoramidite through standard 
phosphitilation for use in solid phase oligonucleotide synthesis. Another method of dimer 
formation coupled a 3´-aminonucleoside with a 3´-O-Levulinyl protected nucleoside converted 
to a phosphonate ester in the presence of carbon tetrachloride and triethylamine in an Atherton-
Todd procedure.3.29  Conventional phosphitilation following 3´-deprotection yielded the dimer 
phosphoramidite for use in solid phase oligonucleotide synthesis.  This method was later 
converted to a synthesis performed directly on the solid support.  The attached nucleoside was 
converted to a phosphonate ester which was then coupled with a 3´-aminonucleoside in the 
presence of carbon tetrachloride/triethylamine to form the phosphoramidate linkage.3.30,3.31  
Repeated couplings were performed to yield the all phosphoramidate oligonucleotide.  This solid 
phase procedure was later performed using an oxidative phosphorylation reaction in which the 
coupling of the 3´-aminonucleoside with the phosphonate ester is activated by iodine.3.32 
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 As the stepwise yields for the above reported oligonucleotides were similar the solid 
phase methods using carbon tetrachloride/triethylamine and iodine as activation agents of 
coupling were used for the synthesis of the oligonucleotides used in the experiments described 
below.  The 3´-aminothymidine was synthesized by reduction of the azido group with sodium 
borohydride of a 5´-dimethoxytrityl-protected 3´-azidothymidine (Scheme 3.1).  The 3´-
aminothymidine was then coupled to a solid supported nucleoside phosphoramidite which had 
been converted to a 5´-H-phosphonate-2-cyanoethyl diester (Scheme 3.2).  Conventional steps 
for solid phase oligonucleotide synthesis (Scheme 3.3) were then performed to yield an 
oligonucleotide containing only one penultimate 3´ N3´→ P5´ phosphoramidate backbone 
modification.      
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Scheme 3.1.  Reduction of 3´-DMT azidothymine. 
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Scheme 3.3.  Solid phase DNA synthesis by the cyanoethyl phosphoramidite approach. 
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3.2    Exonuclease Resistance of Phosphoramidate 
 
 In order to test the extension efficiency and exonuclease resistance of 3´-
phosphoramidate modifications and compare it to that of a 3´-phosphorothioate modification and 
the natural phosphodiester backbone, three primers containing a natural phosphodiester bond, a 
phosphorothioate bond, or a phosphoramidate bond in the penultimate 3´-position were extended 
on a template with either a C-G match (Match template) or a C-A mismatch (Mismatch 
template).  Template and primer sequences are shown in Figure 3.3.  The extensions were 
performed with Taq DNA polymerase which has no exonuclease activity and Vent and Pfu DNA 
polymerases which do contain 3´-5´ exonuclease domains.  From these extension reactions could 
be quantitated the amount of extension product for each primer extended with each enzyme to 
determine the efficiency by which the polymerase extends the phosphoramidate and compare this 
with the efficiency of the phosphodiester and phosphorothioate primers.  A time-dependent 
cleavage assay was also developed in which Vent and Pfu DNA polymerases were provided 
dNTPs that would not form Watson-Crick base pairs with the next two bases in the template 
strand.  This assay allowed the qualitative analysis of the rate of phosphorothioate and 
phosphoramidate modification cleavage.   
 
 
Figure 3.3.  Sequences of the primers as well as the match and mismatch templates used in the 
assay to test the exonuclease resistance of the phosphoramidate modification. 
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 When the primer is annealed and extended to the match template there is a BslI restriction 
endonuclease site which can be utilized to check if the enzyme correctly extended the primer 
strand (Figure 3.4).  The annealed and extended primer/mismatch duplex contained a TaqαI 
restriction endonuclease site if and only if the exonuclease domain of the DNA polymerase 
removed the mismatched base, which is linked via the modification, from the primer.  By 
measuring the extent of  TaqαI cleavage the extent to which the mismatched base was removed 
can be measured.  The amount of cleavage is equivalent to the exonuclease resistance of the 
phosphoramidate and phosphorothioate modifications which can be compared to that of the 
natural phosphodiester backbone. 
 
 
Figure 3.4.  The assay designed to test the exonuclease resistance of the phosphoramidate 
modification. 
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 Figure 3.5 shows the radiolabeled primers and resulting products formed in the assay 
separated on a polyacrylamide electrophoresis gel.  The determination of extension efficiency of 
the primers by the polymerases indicated that both the phosphorothioate and phosphoramidate 
modifications were recognized by all of the polymerases tested.  The extension efficiencies of all 
three primers annealed to the match template are quite similar indicating that the incorporation of 
these backbone modifications does not affect the catalysis performed by the polymerase.  
Although it was expected that even with a mismatch the phosphoramidate containing primer 
would be extended with greater efficiency due to the A-form conformation adopted, the 
extension efficiency of the phosphoramidate containing primer was greatly reduced with all three 
DNA polymerases.  This is possibly due to the fact that the A-form conformation is adopted 
because the sugar pucker is changed to C3´-endo which may disrupt the formation of the closed 
conformation of the polymerase catalytic active site.  Due to the observation that the 
phosphorothioate containing primer also reduced extension efficiency of the primer/mismatch 
duplex another possible explanation for the reduced efficiency may be that the primer spends 
more time in the exonuclease domain since the mismatch is not corrected.  The phosphoramidate 
primer has more hydrogen bonding capability than the phosphorothioate primer which may make 
the binding of the former more favorable than the latter which indicates that the phosphoramidate 
may spend more time in the exonuclease domain than either the phosphodiester or the 
phosphorothioate primers. 
 In the evaluation of the exonuclease resistance of the backbone modifications the BslI 
restriction digest interestingly shows reduced cleavage of the phosphorothioate and 
phosphoramidate primers (Table 3.1).  The modifications are contained within the reading frame 
of the restriction endonuclease which may decrease binding of the enzyme to these modified  
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Figure 3.5.  Electrophoretic gels of the assay to test the exonuclease resistance of the 
phosphoramidate modification extended by A. Taq, B. Vent, or C. Pfu DNA polymerase.  
O=phosphodiester; S=phosphorothioate, N=phosphoramidate.  Extension reactions were 
performed with 20 pM primer, 50 pM template, and 200 µM solution of all four dNTPs,  
AmpliTaq®, Vent, and Pfu polymerases and the supplied buffers.  Extension of the match 
template was digested with BslI restriction endonuclease (supplied buffer: 1 M NaCl, 500 mM 
Tris-HCl, 100 mM MgCl2, 1 mM DTT, pH 7.9) at 55 ºC for 60 min.  Extension of the mismatch 
template was digested with TaqαI restriction endonuclease (supplied buffer: 1 M NaCl, 100 mM 
Tris-HCl, 100 mM MgCl2, pH 8.4) at 65 ºC for 60 min. 
A. 
B. 
C. 
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primers.  The amount of TaqαI restriction endonuclease cleavage of the mismatched template 
extension product is equivalent to the extent of correction and therefore gives an indication of 
modification stability.  With Vent DNA polymerase nearly complete cleavage of the 
phosphodiester primer can be compared with 75% cleavage of the phosphorothioate primer, and 
only 16% cleavage of the phosphoramidate primer.  Although mismatch extension of the 
phosphorothioate and phosphoramidate primers was not very efficient with Pfu polymerase there 
was nearly complete cleavage of the phosphodiester primer, and only small amounts of cleavage 
of the phosphorothioate and phosphoramidate primers.  These results indicate that the 
phosphoramidate primer affords the greatest stability and therefore the greatest protection against 
exonuclease activity. 
Table 3.1.  Quantitation of percentages of extension and cleavage of each primer. 
Match Template: 
 Taq Polymerase Vent Polymerase Pfu Polymerase 
 % extension % cleavage % extension % cleavage % extension % cleavage 
O 99% 59% 99% 74% 97% 74% 
S 93% 41% 93% 38% 91% 15% 
N 96% 1% 85% 3% 95% 3% 
Mismatch Template: 
O 53% <1% 99% 99% 80% 58% 
S 67% <1% 72% 75% 10% 7% 
N 37% <1% 39% 16% 3% 1% 
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Figure 3.6.  Electrophoretic gels of the timed analysis of exonucleolytic cleavage of the 
phosphodiester (O), phosphorothioate (S), and phosphoramidate (N) primers.  Reactions were 
performed as extension reactions as described in Figure 3.5 without the addition of dATP and 
dGTP. 
 
 
Analysis of the time-dependent cleavage assay shows cleavage of the phosphodiester 
primer after 5 s, cleavage of the phosphorothioate primer after 5 min and no cleavage of the 
phosphoramidate primer even after 30 min with Pfu DNA polymerase (Figure 3.6).  Once again 
it was shown that the phosphoramidate modification exhibits greater exonuclease resistance 
when compared with the natural phosphodiester or the phosphorothioate modification. 
 There are a number of possibilities as to the reason for the increased exonuclease 
resistance of the phosphoramidate backbone modification.  In the mechanism of exonucleolytic 
cleavage introduced in Chapter 1 a metal ion binds to the 3´-oxygen.  The metal ion provided in 
the assays described above was Mg2+, which may have a higher affinity for binding oxygen 
rather than nitrogen due to the lower electronegativity of nitrogen.  As was mentioned earlier in 
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respect to the structural studies done on phosphoramidate containing oligonucleotides it was 
found that there is more hydration in the grooves due to the greater hydrogen bonding donating 
properties of nitrogen as compared with oxygen.  Also in the structural studies the anomeric 
effect between the antibonding orbital of the P-O5´ bond and the lone pair of nitrogen caused a 
configuration that allowed for the binding of chlorine ions to the nitrogen.  Due to binding of 
chlorine ions and water there may be steric hindrance to the binding of the Mg2+ metal ion which 
is crucial for exonucleolytic cleavage to occur.  A final possibility for the increased exonuclease 
resistance of the phosphoramidate modification may be due to the inability of the nitrogen to 
stabilize the negative charge generated after nucleophilic attack of the phosphorous by a 
hydroxide ion due to the decreased electronegativity of nitrogen compared with oxygen. 
3.3   Conclusions 
 
 The N3´→ P5´ phosphoramidate backbone modification is resistant to the exonucleolytic 
cleavage of Vent and Pfu DNA polymerases.  It has been shown that this backbone modification 
is more exonuclease resistant than the natural phosphodiester backbone and the much used 
phosphorothioate modification.  This modification would be of great use in PCR primers, the 
PCR/RE/LDR mutation detection strategy, and other point mutation detection strategies utilizing 
strategically placed mismatches.   
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Chapter 4:  Capillary and Microdevice Electrophoresis of LDR 
 
4.1 Introduction 
4.1.1 LDR of Colorectal Cancer 
Point mutations occurring in the K-ras gene have been shown to be good biomarkers for 
colorectal cancers.4.1-4  30-50% of all colorectal cancers contain a point mutation in codons 12, 
13, and 61 in the K-ras gene (Figure 4.1).  These point mutations are conserved throughout the 
history of the disease which makes these mutations suitable for detection of these cancers.  In the 
early stages of colorectal cancer there are low copy numbers of mutated DNA as compared with 
normal or wild type DNA.  Early detection of colorectal cancer requires the detection of these 
low level mutations which is made difficult by the large amount of normal DNA present.  
0 200 400 600 800 1000Kb
12 13 61
PCR of  exon 
containing codon 12
GGT
CCA
Wild Type
     Gly
GTTCys
GCTArg
GATSer  
Figure 4.1.  Locations of codons 12, 13, and 61 in the K-ras gene. 
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Figure  4.2.  Schematic representation of the ligase detection reaction (LDR). 
 
The ligase detection reaction (LDR) was designed as a point mutation detection strategy 
in order to identify such low abundant mutations.4.5-8  In LDR (Figure 4.2) oligonucleotide 
primers (a common and all possible discriminating primers) are annealed adjacently to one 
strand of the target DNA.  The adjoining discriminating and common primers are covalently 
joined by a thermostable DNA ligase to form an LDR product if the target nucleotide at the 
mutation site is complementary to the 3´-end of the discriminating primer.   All possible 
mutations at a specific site can be analyzed by including all possible discriminating primers (of 
differing lengths) corresponding to the possible nucleotide substitutions.  Generation of an LDR 
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product indicates the presence of a mutation while the size of the product indicates which 
specific substitution is present. LDR products were first analyzed by slab gel electrophoresis.  
This method made use of fluorescein labeled discriminating primers and a phosphorylated 
common primer, both in excess of the target DNA to which the primers were annealed.  This 
excess of discriminating primers and common primer is required to ensure complete annealing of 
the target DNA and efficient ligation.  This surplus of primers causes annealing competition 
when the assay is used for analysis of multiple mutations or multiplexing.  Using this analysis 
method a 1:1000 ratio of mutant to wild type sequences could be discriminated.   
In an effort to better analyze products of the LDR strategy capillary and microdevice 
electrophoresis was employed.  These electrophoresis formats not only decrease time of analysis 
but also increase resolution.    
4.1.2 Capillary and Microdevice Electrophoresis 
Capillary electrophoresis (CE) consists of two buffer reservoirs with a separation 
capillary filled with a carrier electrolyte making electrical contact between them4.9-13  Samples 
are loaded onto the capillary either electrokinetically, by applying an electric field from the 
sample reservoir to the waste reservoir, or hydrodynamically, by applying an external pressure to 
the sample container.  The sample is then separated by the application of an electric field and 
detected by an online detector close to the outlet of the capillary.  In order to separate DNA a 
sieving matrix must be used inside the capillary tube.  These sieving polymers can either be 
cross-linked or linear, with the choice mandated by the required resolving power and the ease of 
use.4.14-20  While the cross-linked gels typically provide better resolving power than the linear 
gels, the linear gels can be replaced in the capillary while cross-linked gels cannot.  The 
replacement of the linear gels is required due to the deleterious effects of the high electric field 
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on the gel.  Detection can be accomplished by either ultraviolet absorbance or by fluorescence 
using intercalating dyes or covalently linked fluorophores for laser induced fluorescence (LIF) 
detection.  Since most CE analyses use only nanoliter volumes of sample, highly sensitive 
detection is required; therefore in most cases LIF is used in CE applications. 
CE has been used in the analysis of a multitude of mutation detection strategies.  Some 
more recent examples include the detection of mutations in the BRCAI and BRCA2 breast cancer 
susceptibility genes by the single strand conformation polymorphism (SSCP) and heteroduplex 
analysis (HDA) methods which employed the use of CE.4.21  The percentage of mutations 
detected was increased to 100% efficiency.  CE was also used to analyze the products of a 
minisequencing assay to detect mutations in the CYP21 gene, which causes a deficiency in the 
21-hydroxylase enzyme.4.22 
The first microdevices developed for electrophoretic purposes were constructed on glass 
microscope slides and produced comparable resolution to conventional CE but at a fraction of 
the time.4.23,4.24  Electrophoresis on a planar chip builds on the inherent advantages associated 
with CE, including high surface-to-volume ratios produced by using very small channels for the 
separation, which permit the application of higher electric fields for faster separations.  
Microdevices have been applied to the separation of DNA in a variety of genetic applications 
ranging from the simple sizing of PCR products to mutation detection strategies such as SSCP 
and HDA.4.25  The simplest device format for performing electrophoresis is the twin T design, 
which contains a cross-like structure.4.26,4.27 (Figure 4.3)  The “arms” of the T are used for 
electrokinetic injection of sample and are offset to define a fixed injection volume, while the 
longer channel is used for separation.  A sieving matrix is introduced into the device as in CE.  
The switching of voltages from well to well allows the loading and separation of samples. 
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Figure 4.3.  The twin T microdevice.  A is the waste well, B is the sample well, C is the buffer 
reservoir and D is the separation well. 
 
 
4.2 Capillary Electrophoresis:  Model Studies and LDR Reactions 
4.2.1 Introduction 
CE has been applied to a number of different mutation detection strategies.  A problem 
caused in the CE analysis of LDR reactions is the electroosmotic flow (EOF) caused by severe 
injection biases.4.28  These injection biases are due to the large excess of LDR primers in the 
reactions in comparison with LDR products produced.  In order to detect the low concentrations 
of LDR products higher injection voltages and times were required which in effect caused a 
reduction in resolution.  In order to choose a suitable matrix for LDR analysis and to prove that 
an LDR product could be resolved in a large excess of primers, model studies using synthetic 
oligonucleotides were performed.  LDR reactions containing varying ratios of mutant and wild 
type templates were also analyzed by CE.  
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4.2.2 Model Studies 
A 25 nucleotide oligonucleotide which was fluorescein labeled on its 5´-end was used to 
simulate the labeled discriminating primers while 44 and 51 nucleotide fluorescein labeled 
oligonucleotides were used to simulate the LDR products which were to be resolved.  In an LDR 
reaction, which contains a 1:20 molar ratio of mutant DNA template to wild type template, the 
ratio of LDR product to excess discriminating primers becomes 1:2 if DNA ligase ligates 
annealed primers at 100% efficiency.  In an LDR reaction that has a 1:1000 ratio of mutant to 
wild type templates, the ratio of LDR products to discriminating primers becomes 1:100 (if the 
reaction is 100% efficient).  If the ligation efficiency falls below 100% then the ratio of LDR 
product to discriminating primer becomes much higher.  Therefore, samples containing 1:10, 
1:100, and 1:1000 molar ratios of 25 to 44 and 51 nucleotide model oligonucleotides were 
analyzed for optimization of separation conditions and testing of sieving matrices.   
The matrices tried were the POP5 performance optimized polymer separation matrix 
(herein referred to as POP5), the eCap ssDNA 100-R Gel matrix (herein referred to as eCap), and 
the µ-PAGE-5 (5%T, 5%C) (indicating the amount of crosslinking present in the acrylamide 
capillary) 5T5C capillary (herein referred to as 5T5C).  The POP5 and eCap gels are replaceable 
linear entangled polymers while the 5T5C capillary is a multiple run cross-linked capillary.  
Conditions for injection and separation were optimized separately for each matrix. While the 
1:10 and 1:100 molar ratios of mock LDR product to mock discriminating primer were able to be 
separated using all of the matrices only the 5T5C was able to separate the 1:1000 ratio due to the 
large injection biases caused by extended times and voltages required during injection.   
The use of the POP5 gel not only was unable to separate the 1:1000 model sample but 
there was severe loss of resolution if the gel was used for more than one injection.  This required 
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refilling the capillary after each run.  The total run time to separate the model samples with POP5 
was found to be just over 30 minutes.  Separation of the 1:100 model sample using POP5 can be 
seen in Figure 4.4.  The eCap gel while also unable to separate the 1:1000 model sample did not 
show a loss in resolution until after five runs and the separation of the oligonucleotides was 
performed in approximately 28 minutes.  Figure 4.5 is an electropherogram of the 1:100 model 
sample using the eCap matrix.  The shorter separation time required combined with the ability of 
eCap to sustain up to five runs decreases the time requirement for analysis.  The 5T5C capillary 
was able to separate all three of the model samples tested and with better resolution than the 
linear gels although with longer migration times (Figure 4.6).  The migration times did vary 
among runs (The 44 fragment migrated at 37 min in the 1:100 sample while at 40 minutes in the 
1:1000.) due to the required clipping of the capillary which is necessary due to bubbles and other 
abnormalities formed from the higher voltages and times required for injection.  It can be seen in 
the electropherograms using 5T5C that the peak height of the 51-nucleotide fragment is not 
equivalent to that of the 44-nucleotide fragment although they were in equimolar concentrations 
in the sample.  This is possibly a reflection of the different labeling efficiencies with fluorescein 
during synthesis or possibly another artifact of the severe injection biases.  
4.2.3 LDR Reactions       
LDR reactions were performed using DNA templates containing a G12V mutation in 
codon 12 of the K-ras gene.  Three labeled discriminating primers were included to probe for all 
of the possible point mutations (G12V, G12A, G12D) at this location of codon 12.  The 
discriminating primers were of 24-, 25-, and 26-nucleotides and the phosphorylated common 
primer was of 20-nucleotides in length.  Sequences of the LDR primers used are shown in Figure  
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Figure 4.4.  Analysis of 1:100 model sample using the POP5 matrix.4.29  The samples were run 
at 12 kV and capillary temperature was controlled at 50 ºC. 
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Figure 4.5.  Analysis of the 1:100 model sample using the eCap matrix.4.29  Samples were run at 
12 kV at 30 ºC. 
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Figure 4.6.  5T5C analysis of the A) 1:100 model sample and B) 1:1000 model sample.4.29  
Samples were run at 250 V at 25 ºC. 
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Discriminating Primers:
c12.2V        5’-Fluor CAA AAA CTT GTG GTA GTT GGA GCT GT-3’    26nt
c12.2A        5’-Fluor CAA AAC TTG TGG TAG TTG GAG CTG C-3’       25nt
c12.2D        5’-Fluor AAA ACT TGT GGT AGT TGG AGC TCA-3’          24nt
Common Primer:
c12 com-2   5’-pTGG CGT AGG CAA GAG TGC CT-3’     20nt  
Figure 4.7.  LDR primer sequences used in reactions for CE analysis. 
 
 
4.7.  Since only the G12V template was used in the reaction only a 46-nucleotide LDR product 
was expected.  After cycling the LDR reactions they were desalted so as to decrease any further 
injection biases caused by the salts required in the reactions.   
As the 5T5C capillary was found to perform the highest resolution separations as 
compared to the POP5 and eCap linear gels, this separation matrix was used in analysis of the 
LDR samples.  An LDR blank sample was prepared by performing an LDR reaction containing 
no template (Figure 4.8).  This sample was used as a negative control.  All that is evident in the 
electropherogram is the large discriminating primer peak.  LDR samples were prepared using 
both a 1:20 and 1:100 molar ratios of mutant to wild type DNA template.  When the 
electropherograms of these samples are compared with that of the LDR blank sample the 
generation of the 46-nucleotide LDR product is apparent (Figure 4.9).  As the amount of mutant 
template is decreased resolution between the discriminating primer peak and the LDR product 
peak is greatly reduced.  As in the model studies, inconsistent migration rates were observed.    
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Figure 4.8.  LDR blank sample for CE analysis.4.29  Samples were run as described in Figure 4.6. 
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Figure 4.9.  A)1:20 and B) 1:100 mutant to wild type LDR reactions for CE analysis.4.29  
Samples were run as described in Figure 4.6. 
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4.3 Microdevice Electrophoresis:  Model Studies 
The microdevice used in these studies was of a modified twin T design (Figure 4.10) in 
which the separation channel was lengthened and contained two turns.  The microchannel was 
hot-embossed in poly (methyl methacrylate) (PMMA) using a mold master produced by a LIGA 
process.  The final device used was assembled by annealing a PMMA cover plate to the open 
face of the device at elevated temperatures in a circulating air oven.  The separation channel was 
10 cm in length and the side channels were 0.5 cm.  There are four wells labeled A, B, C, and D.  
Well A is the sample well, B the waste well, C the buffer reservoir, and D the separation well.  
During injection a positive voltage was placed on waste well B while the sample well A was 
grounded.  During separation a positive voltage was applied to well D while C was grounded and 
positive voltages of 15 and 10% of the voltage applied to D was applied to the sample well A 
and waste well B to prevent diffusion of remaining sample in these wells into the separation 
channel.  A detector designed in the research lab of Dr. Steven Soper accomplished the LIF 
detection.   
 
Figure 4.10.  Modified twin T design used in the current described analysis.  A is the sample 
well, B the waste well, C the buffer reservoir and D the separation well.  During injection a 
positive voltage was placed on waste well B while the sample well A was grounded.  During 
separation a positive voltage was applied to well D while C was grounded and positive voltages 
of 15 and 10% of the voltage applied to D was applied to the sample well A and waste well B. 
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POP5 and eCap matrices were not used in the CE analysis of LDR reactions due to the 
severe injection biases.  These injection problems are alleviated in the microdevice format due 
the ability to switch voltages during injection and separation and the volume based injection as 
compared with the electrokinetic injection of CE.  POP5 was chosen as a matrix for analyzing 
model samples, as described above, in the microdevice electrophoresis format.  The model 
samples were used to optimize the electrophoretic injection as well as separation conditions for 
analysis.  A separation of the labeled 25-nucleotide and 51-nucleotide model sample was 
performed with no voltage pullbacks on wells A and B during separation (Figure 4.11).  
Although the entire microchannel was 10 cm, detection was performed at 3.5 cm before the first 
turn in the modified twin T.  The lack of pullback voltages leads to severe band broadening in 
the form of tailing due to the leakage of residual sample from injection into the separation 
channel during separation.  When pullback voltages are applied and detection is performed at 9.5 
cm tailing is eliminated (Figure 4.12).  A 1:100 model sample of 44- and 51-nucleotide LDR 
product mimics to 25-nucleotide discriminating primer mimic was prepared and analyzed by 
microdevice electrophoresis with the optimized conditions described above.  Very good 
resolution was obtained with this sample as can be seen in Figure 4.13.  The major problem with 
microdevice electrophoresis still to be studied is the lack of complete reproducibility due to the 
manual loading of the microchannel.  The lack of suitable technology to fill the microchannel 
with separation matrix is the foremost concern of applying microdevice electrophoresis to 
mutation detection strategies.   Further model studies and analysis of LDR products need to be 
performed to prove the efficiency of microdevice electrophoresis.   
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Figure 4.11.  Microdevice analysis of a 1:1 model sample of the 25-nucleotide and 51-nucleotide 
oligonucleotides. 4.29  POP5 was the matrix used and no pullback voltages were applied during 
separation.  Injection was at 500 V for 5 s and separation was at 3.5 kV. 
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Figure 4.12.  Microdevice analysis of a 1:1 model sample of the 25-nucleotide and 51-nucleotide 
oligonucleotides.  POP5 was the matrix used and pullback voltages were applied during 
separation.4.29  Injection was at 500 V for 5 s and separation was at 3.5 kV.  Pullback voltages on 
the sample and waste wells during separation were 500 and 300 V, respectively. 
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Figure 4.13.  Microdevice analysis in POP5 of the 1:100 model sample.4.29  Samples were 
separated as described in Figure 4.12. 
 
 
 
4.4 Conclusions 
Although not completely studied, microdevice electrophoresis of LDR reactions is more 
efficient and superior in resolution to CE analysis, while both CE and microdevice 
electrophoresis are superior to slab gel electrophoresis in time and resolution.  The use of this 
technology for analyzing mutation detection strategies increases resolution and decreases time 
which is essential for the ultimate goal of microdevice electrophoresis:  doctor’s office 
evaluation of disease.  These small devices, when completely optimized, will be a breakthrough 
for diagnostic care. 
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Chapter 5:  Experimental Details 
5.1    Nucleoside Base Analogs-Chapter 2 
5.1.1 Synthesis of 1-(β-D-2´-deoxyribofuranosyl)-4-(2-thiazolyl)-pyrazole 
In an inert atmosphere Pd(PPh3)4 (0.05 g, 0.05 mmol) was dissolved in dry THF (10 mL).  
To this was added thiazolyl zinc bromide (2.7 mL of a 0.5 M solution, 1.4 mmol) after which 1-
(β-D-2´-deoxyribofuranosyl)-3´,5´-bis-O-(p-toluoyl)-4-iodo-pyrazole (0.5 g, 0.9 mmol) was 
added to the Pd-thiazole mixture.  The reaction was stirred for 1 h after which another 0.05 eqiv 
of Pd(PPh3)4 was added to the reaction.  This was repeated three more times to reach a final 25 
mol% of palladium catalyst.  THF was evaporated under reduced pressure and the reaction was 
washed with NH4Cl (20 mL), ether (3 x 20 mL), and dried over CaCl2.  The product was purified 
by column chromatography (2:1 hexanes:ethyl acetate) to yield a yellow oil in 90% (0.4 g).  1-
(β-D-2´-deoxyribofuranosyl)-3´,5´-bis-O-(p-toluoyl)-4-(2-thiazolyl)-pyrazole (0.3 g, 0.6 mmol) 
was dissolved in methanol (20 mL) to which was added sodium methoxide (0.2 M, 20 mL).  The 
reaction was stirred for 2 h after which acetic acid (5 mL) was added to quench.  The solvent was 
evaporated under reduced pressure and the white solid dissolved in chloroform in which sodium 
acetate precipitated and was filtered.  The product was purified by radial chromatography (9:1 
CHCl3:CH3OH) to yield a white foam in 63%.      
1-(β-D-2´-Deoxyribofuranosyl)-4-(2-thiazolyl)-pyrazole was converted to the 5´-
dimethoxytrityl protected 3´-O-2-cyanoethyl-N,N-diisopropylphosphoramidite as previously 
described for incorporation into an olidodeoxynucleotide.5.1  The above-mentioned compounds 
were characterized by 1H and 31P NMR as previously described.5.1 
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5.1.2 Computational Analysis of Pyrazole-Based Analogs 
Bases with a hydrogen atom at the sugar attachment point were drawn in Hyperchem 6.0 
(Hypercube, Inc.) and minimized with a Polak-Ribiere conjugate gradient miniminization 
technique (leaving all values as default) using the MM+ force field.  RMS fits with crystal 
structure data were found to be 0.06 or less for each analog.  Semiempircal PM3 calculations 
produced the QSAR properties of surface area, dipole moment and polarizability values for each 
analog.   
5.1.3 DNA Polymerase Extension Reactions of Pyrazole Analogs 
Templates and primers were synthesized by cyanoethyl phosphoramidite chemistry at a 
1.0 µmol scale on an Applied Biosystems 394 DNA/RNA Synthesizer using a standard 500 Å 
CPG column.  Coupling times were doubled for the incorporation of thiazolylpyrazole and 
nitropyrazole analog phosphoramidites.   
 All oligonucleotides were purified by electrophoresis on a 20% polyacrylamide/7 M urea 
gel.  The bands were visualized by UV shadowing, excised from the gel, and eluted overnight at 
37 ºC in a 1X elution buffer (0.1% SDS, 0.5 M ammonium acetate, and 10 mM magnesium 
acetate OR 0.5 M NaCl, 5 mM EDTA, pH 8.0).  The eluant was purified with a C18 Sep Pak 
(Waters).  Finally, the oligonucleotides were quantified by UV absorbance at 260 nm. 
 Primers were 5´-end 33P-labeled using T4 Polynucleotide Kinase (New England Biolabs) 
(10 U/50 pmol primer) and (γ-33P)ATP (Amersham) (150 µCi/50 pmol primer) and purity 
analyzed by electrophoresis on a 12% polyacrylamide/ 7 M urea analytical gel. 
 Extension reactions were performed in 20 µL with 250 nM radiolabeled primer and 
template, and 200 µM solution of all four dNTPs, polymerase and the supplied buffer. The 
following polymerases and buffers were used: 
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(a) 5 U AmpliTaq® DNA polymerase with supplied 10X Reaction Buffer (100 mM Tris-
HCl pH 8.3, 500 mM KCl) (Perkin-Elmer).  An additional 8 mM MgCl2 was added to the 
reaction. 
(b) 2.5 U Klenow fragment (exo-) DNA polymerase with supplied 10X Reaction Buffer (100 
mM Tris-HCl pH 7.5, 5 mM MgCl2, 7.5 mM dithiothrietol) (New England Biolabs) 
Extension reactions were stopped at the appropriate time by the addition of 20 µL gel loading 
buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol FF) 
and the products elecrophoresed on a 12% polyacrylamide/7 M urea analytical polyacrylamide 
gel.  After drying for 2 h at 80 ºC the gel was imaged on a Molecular Dynamics phosphorscreen 
imaging plate then read on a Storm 840 scanner and analyzed using Molecular Dynamics Image-
Quant software.  The electrophoresis lanes were subjected to area analysis which created an 
electropherogram based on the intensities of the imaged bands.  The area of the product peak was 
divided by the sum of the areas of the all of the peaks in the lane.  This value was multiplied by 
100 to obtain the percentage of extension.      
5.1.4   Synthesis of Thiazole and Thiazole N-oxide Analogs5.2 
5.1.4.1  Synthesis of 2-deoxy-3,5-di-O-p-toluoyl-β-D-erythro-pentofuranosyl cyanide (2) 
Chlorosugar 1 (4.23 g, 10.9 mmol) was dissolved in dry DME (100 mL), sodium cyanide 
(2.14 g, 43.60 mmol) was added, and the mixture was stirred for 24 h at room temperature under 
argon.  The solvent was evaporated and the resulting yellow oil was dissolved in 200 mL EtOAc 
then extracted with sat. aq. NaHCO3 (1 x 100 mL) and sat. aq. NaCl (1 x 100 mL).  The organic 
layer was dried over Na2SO4, filtered and evaporated to a white solid.  Purification by silica gel 
flash chromatography using hexanes/EtOAc as eluant provided cyanosugar 2 as a 3.2:1 ratio of 
β/α anomers in 83% yield (3.18 g).  For ease of purification, this anomeric mixture was used 
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directly in the following reaction.  Rf=0.63 (50% EtOAc/Hexanes);  1H NMR (250 MHz, CDCl3, 
β anomer) δ 7.92 (m, 4H), (m, 4H), (m, 1H), (dd, 0.75H, J=2.6, 6.6 Hz, β-anomer), 4.56 (m, 3H), 
2.70 (m, 2H), 2.41 (s, 6H);  13C NMR (62.5 MHz, CDCl3) 166.1, 166.0, 144.6, 144.1, 129.9, 
129.7, 129.6, 129.2, 126.6, 126.2, 117.9, 83.8, 75.4, 74.8, 66.5, 65.8, 63.7, 63.6, 37.8, 21.7. 
5.1.4.2 Synthesis of 2,5-anhydro-3-deoxy-4,6-di-O-p-toluoyl-D-ribo-hexonthioamide (3) 
Hydrogen sulfide was condensed into a pressure vial cooled to -77 °C containing a 3.2:1 
β/α anomeric mixture of cyanosugar 2 (3.10 g, 8.17 mmol) and dimethylaminopyridine (50 mg, 
0.041 mmol).  The vessel was sealed and allowed to warm to room temperature.  After 24 h, the 
pressure vial was cooled to –77 °C and opened, then allowed to slowly warm to room 
temperature.  The resulting yellow foam was coevaporated with 2 x 50 mL of dichloromethane, 
then purified by silica gel chromatography using hexanes/ethyl acetate as eluant to provide 
thioamide 3 in 61% yield (2.06 g). Rf=0.57 (50%EtOAc:Hexanes);    1H NMR (250 MHz, 
CDCl3) δ 8.37 (s, 1H), 7.92 (m, 4H), 7.63 (s, 1H), 7.27 (m, 4H), 5.48 (d, 1H, J=5.6 Hz), 5.11 
(dd, 1H, J=5.9, 4.7), 4.63 (m, 3H), 2.86 (dd, 1H, J=6, 8.2 Hz), 2.26 (m, 1H). ); 13C NMR (62.5 
MHz, CDCl3) 205.3, 166.7, 165.9, 144.2, 129.6, 129.5, 129.2, 129.1, 126.3, 84.9, 84.8, 75.7, 
64.3, 40.0, 21.5;  FAB(+)HRMS calcd for C22H24NO5S (M+H)+ 414.1392, found 414.1365. 
5.1.4.3 Synthesis of 2-(2´-Deoxy-3´,5´-di-O-p-toluoyl-β-D-ribofuranosyl)thiazole (4) 
A.  Thioamide 3 (1.16g, 3.0 mmol) was dissolved in THF (33 mL) and EtOH (16 mL).  
50% chloroacetaldehyde solution (3.18 mL, 25 mmol) was added and the reaction refluxed for 
24 h.  Another equiv of chloroacetaldehyde solution  (3.18 mL, 25 mmol) was added and the 
reaction refluxed for another 24 h period.  The solvents were evaporated and the residue 
dissolved in ethyl acetate, extracted with saturated aq. NaHCO3 (1 x 100 mL) and saturated aq. 
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NaCl (1 x 100 mL), and dried over MgSO4.  Silica gel column chromatography with ethyl 
acetate/hexanes yielded 42% as a light yellow solid.      
B.  Thioamide 3 (0.50 g, 1.21 mmol) was dissolved in 7.1 mL of dry acetone, and 0.9 mL 
(0.69 g, 3.5 mmol) of bromoacetaldehyde diethyl acetal, followed by 13 µl of a 4 M HCl/dioxane 
solution, was added.  The resulting clear solution was refluxed under argon for 24 h.  The brown 
colored solution was evaporated to a dark oil, then dissolved in 100 mL EA and extracted with 
saturated aq. NaHCO3 (1 x 100 mL) and saturated aq. NaCl (1 x 100 mL).  The organic layer was 
dried over Na2SO4, filtered and evaporated to a dark brown liquid.  Purification by silica gel 
chromatography with hexanes/EA provided tol-thiazole 4, a light brown gum, in 70% yield 
(0.370 g).  Crystallization from ethanol provided the title compound as a solid.  1H NMR (250 
MHz, CDCl3) δ 7.93 (m, 4H), 7.74 (d, 1H, J=3.4 Hz), 7.24 (m, 5H), 5.62 (m, 2H), 4.61 (m, 3H), 
2.78 (m, 1H), 2.47 (m, 1H), 2.43 (s, 3H), 2.39 (s, 3H);  13C (62.5 MHz, CDCl3) 171.4, 166.2, 
166.0, 144.2, 143.8, 142.6, 129.7, 129.2, 129.1, 126.9, 126.7, 119.1, 83.5, 78.8, 76.7, 64.4, 40.2, 
21.6;  FAB(+)HRMS calcd for C24H24NO5S (M+H)+ 438.1392, found 438.1382. 
5.1.4.4  Synthesis of 2-(2´-Deoxy-3´,5´-di-O-p-toluoyl-β-D-ribofuranosyl)thiazole-N-oxide (5) 
A.  Tol-thiazole 4 (380 mg, 0.87 mmol) was dissolved in ethyl acetate (5 mL) and m-
chloroperoxybenzoic acid (320 mg, 1.85 mmol) was added.  The stirred reaction was allowed to 
proceed for 72 h, then purified by silica gel column chromatography using ethyl 
acetate/methanol as eluant to provide tol-thiazole N-oxide 5, a colorless oil, in 46% yield (180 
mg).  Repeated evaporation from ethyl acetate provided the title compound as a crystalline solid. 
B.   Tol-thiazole 4 (100 mg, 0.23 mmol) was dissolved in dichloromethane (5 mL) after 
which hydrogen peroxide urea complex (43.27 mg, 0.46 mmol) was added and allowed to stir for 
5 min at room temperature.  Trifluoroacetic anhydride (96.61 mg, 0.46mmol) was then slowly 
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added to the reaction and stirred for 1 h.  Na2S2O3 (5 mL) was then added to the reaction mixture 
and allowed to stir for 15 min destroying any residual peroxides.  The organic layer was 
extracted with NaCl (1 X 50 mL) and dried using NaSO4.  The mixture was purified by silica gel 
column chromatography using ethyl acetate/hexanes, which resulted in tol-thiazole N-oxide 5, a 
colorless oil that solidifies at room temperature, resulting in a 97 % yield (101 mg). 
Rf=0.37 (12.5% MeOH:EtOAc);  1H NMR (250 MHz, CDCl3) δ 7.94 (m, 4H), 7.70 (d, 1H, J=4.0 
Hz), 7.27 (m, 5H), 5.77 (dd, 1H, J=5.6, 4.7 Hz), 5.68 (d, 1H, J=5.9 Hz), 4.63 (m, 3H) 3.14 (dd, 
1H, J=8.2, 5.7), 2.45 (s, 3H), 2.42 (s, 3H), 2.31 (m, 1H); ); 13C NMR (62.5 MHz, CDCl3) 166.1, 
149.3, 144.3, 144.0, 137.6, 129.8, 129.6, 129.2, 126.7, 126.5, 117.1, 83.6, 76.6, 75.3, 64.2, 37.8, 
21.7;  FAB(+)HRMS calcd for C24H24NO6S (M+H)+ 454.1341, found 454.1318. 
5.1.4.5  Synthesis of 2-(2´-Deoxy-β-D-ribofuranosyl)thiazole (6) 
Tol-thiazole 4 (220 mg, 0.51 mmol) was dissolved in 16.2 mL of dry methanol, and 0.20 
M sodium methoxide in methanol (5.4 mL) was added.  After 2 h, glacial acetic acid (129 mg, 
2.14 mmol) was added and the solution was evaporated to an oil.  Flash chromatography on 
silica gel with ethyl acetate/methanol as eluant provided 2-(2´-deoxy-β-D-ribofuranosyl)thiazole 
as a white solid in 74% yield (75 mg).  Thiazole 6 was crystallized from benzene, mp 129-131 
°C.  Rf=0.46 (12.5% MeOH:EtOAc);  1H NMR (250 MHz, CD3OD) δ 7.73 (d, 1H, J=3.3 Hz), 
7.52 (d, 1H, 3.3 Hz), 5.42 (dd, 1H, J=6.2, 3.2 Hz), 4.35 (m, 1H), 4.00 (m, 1H), 3.63 (m, 2H), 
2.39 (m, 1H), 2.13 (m, 1H); 13C NMR (62.5 MHz, CDCl3) 175.3, 143.1, 120.7, 89.6, 78.9, 74.0, 
63.9, 43.6;  FAB(+)HRMS calcd for C8H12NO3S (M+H)+ 202.0555, found 202.0542. 
5.1.4.6  Synthesis of 2-(2´-Deoxy-5´-O-dimethoxytrityl-β-D-ribofuranosyl)thiazole (8) 
Thiazole 6 (100 mg, 0.50 mmol) was dissolved in 4 mL dry pyridine.  To this solution 
was added 70 µl of triethylamine (51 mg, 0.50 mmol) and dimethoxytrityl chloride (170 mg, 
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0.50 mmol).  Following 3 h of stirring at room temperature, 0.20 mL of methanol was added and 
the solvents were evaporated.  Flash chromatography on silica gel with hexanes/ethyl acetate 
provided the title compound in 70% yield (170 mg) as a white foam from dry dichloromethane.  
Rf=0.34 (75% EtOAc:Hexanes);  1H NMR (250 MHz, CDCl3) δ 7.70 (d, 1H, J=3.3 Hz), 7.46-
7.23 (m, 10H), 6.80 (d, 4H, J=8.8 Hz), 5.50 (dd, 1H, J=6.2, 2.8 Hz), 4.42 (m, 1H), 4.12 (m, 1H), 
3.76 (s, 6H), 3.30 (m, 2H), 3.04 (bs, 1H), 2.44 (m, 1H), 2.26 (m, 1H);  13C NMR (62.5 MHz, 
CDCl3) 173.2, 158.4, 144.7, 142.3, 135.9, 135.8, 130.0, 128.0, 127.8, 126.7, 118.9, 113.0, 86.6, 
86.1, 77.9, 73.7, 64.0, 55.1, 42.7;  FAB(+)HRMS calcd for C29H29NO5S (M+Na)+ 526.1681, 
found 526.1656. 
5.1.4.7 Synthesis of 2-(2´-deoxy-5´-O-dimethoxytrityl-β-D-ribofuranosyl)thiazole-3´-O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite (9) 
 
DMT-thiazole 8 (80 mg, 0.16 mmol) was coevaporated with dry dichloromethane (3 x 5 
mL), and then dissolved in dichloromethane anhydrous (2 mL).  To this solution was added 2-
cyanoethyl tetraisopropylphosphorodiamidite (152 µl, 0.48 mol), diisopropylamine (22 mL, 0.16 
mmol), and tetrazole (11.2 mg, 0.16 mmol).  The reaction was stirred for 2 h, methanol was 
added (100 µl), followed by dichloromethane (50 mL), the reaction was extracted with 10% 
Na2CO3 (2 x 50 mL) and dried over Na2SO4.  Flash chromatography on silica gel using ethyl 
acetate/hexanes as eluant provided thiazole phosphoramidite 9 as a white foam from dry diethyl 
ether in 89% yield (10 mg).  Mixture of two diastereomers, Rf=0.43, 0.53 (50% 
EtOAc:Hexanes);  1H NMR (250 MHz, CDCl3) δ 7.66 (d, 1H, J=4.1), 7.33 (m, 11H), 6.85 (m, 
4H), 5.53 (dd, 1H, J=5.4, 4.2), 4.54 (m, 1H), 4.29 (m, 1H), 3.81 (s, 6H), 3.63 (m, 3H), 3.38 (m, 
1H), 3.24 (m, 1H), 2.63 (t, 2H, J=6.3), 2.44 (t, 1H, J=6.6), 2.30 (m, 1H), 1.16 (m, 12H); 31P 
NMR (101.2 MHz, CDCl3) (mixture of two diasteromers) δ 150.07, 149.44;  FAB(+)HRMS 
calcd for C8H12NO4S (M)+ 703.2862, found 703.2827. 
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5.1.4.8  Synthesis of 2-(2´-Deoxy-β-D-ribofuranosyl)thiazole-N-oxide (7) 
To tol-thiazole N-oxide 5 (150 mg, 0.33 mmol) dissolved in methanol (10.4 mL) was 
added a 0.20 M solution of sodium methoxide in methanol (3.45 mL, 0.69 mmol).  After 2 h, 
glacial acetic acid was added (42 mg, 0.69 mmol) and the solvents were evaporated to provide a 
thick oil.  Flash chromatography on silica gel using EtOAc/methanol as eluant provided thiazole 
N-oxide 7 as a viscous oil in 83% yield (60 mg).  Rf=0.33 (50% MeOH:EtOAc);  1H NMR (250 
MHz, CD3OD) δ 7.92 (m, 4H), 7.68 (d, 1H, J=4.0), 7.25 (m, 5H), 5.76 (dd, 1H, J=6.6, 4.7), 5.66 
(d, 1H, J=5.9), 4.62 (m, 3H), 3.11 (dd, 1H, J=5.6, 8.3), 2.43 (s, 3H), 2.40 (s, 3H), 2.32 (m, 1H);  
13C NMR (62.5 MHz, CD3OD) 155.7, 137.9, 120.36, 89.4, 75.5, 73.9, 63.6, 41.0;  
FAB(+)HRMS calcd for C8H12NO4S (M+ H)+ 218.0504, found 218.0481. 
5.1.4.9 Synthesis of 2-(2´-Deoxy-5´-O-dimethoxytrityl-β-D-ribofuranosyl)thiazole-N-oxide 
(10) 
 
Thiazole N-oxide 7 (50 mg, 0.23 mmol) was coevaporated with dry pyridine (2 x 5 mL), 
then dissolved in anhydrous pyridine (2 mL).  To this solution was added 33 µl of triethylamine 
(24 mg, 0.23 mmol) and dimethoxytrityl chloride (78 mg, 0.23 mmol).  The mixture was stirred 
for 2 h, then a second equivalent of triethylamine (24 mg, 33 µl) and dimethoxytrityl chloride 
(78 mg, 0.23 mmol) was added.  After an additional 1 h, methanol (0.2 mL) was added, the 
reaction was evaporated to dryness, dissolved in ethyl acetate (50 mL) and extracted with 
saturated aq. NaHCO3 (1 x 50 mL), saturated aq. NaCl (1 x 20 mL) and the organic layer was 
dried over Na2SO4.  The solution was filtered, evaporated to dryness, and purified by flash 
chromatography on silica gel using methanol/dichloromethane as eluant to provide thiazole 
phsphoramidite 9 as a white foam from diethyl ether in 90% yield (110 mg).  Rf=0.25 (12.5% 
MeOH:EtOAc);  1H NMR (250 MHz, CDCl3) δ 7.61 (d, 1H, J=4.1), 7.30 (m, 11H), 6.82 (m, 
4H), 5.73 (dd, 1H, J=5.7, 4.1), 4.49 (bs, 1H), 4.15 (m, 2H), 3.79 (s, 6H), 3.20 (m, 2H), 2.89 (m, 
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1H), 2.14 (m, 1H);  13C NMR (62.5 MHz, CDCl3) 158.9, 145.2, 137.7, 136.4, 136.3, 130.5, 
128.6, 128.2, 127.2, 117.3, 113.5, 87.3, 86.6, 75.2, 74.2, 64.3, 60.8, 55.6, 41.0;  FAB(+)HRMS 
calcd for C8H12NO4S (M)+ 519.1732, found 519.1709. 
5.1.4.10 Synthesis of 2-(2´-deoxy-5´-O-dimethoxytrityl-β-D-ribofuranosyl)thiazole-N-oxide-                        
3´-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite (11) 
 
Thiazole phosphoramidite 9 (110 mg, 0.21 mmol) was dried by evaporation from 
anhydrous dichloromethane (2 x 5 mL), and dissolved in 2 mL dry dichloromethane.  To this 
solution was added diisopropylamine (32 µl, 0.23 mmol), 2-cyanoethyl 
tetraisopropylphosphorodiamidite (89 µl, 0.28 mmol) and tetrazole (16 mg, 0.23 mmol).  The 
solution was stirred for 30 minutes and a second portion of 2-cyanoethyl 
tetraisopropylphosphorodiamidite (57 µl, 0.18 mmol) was added.  The reaction was allowed to 
proceed an additional 20 min., then methanol (0.5 mL), followed by 50 mL of dichloromethane, 
was added.  The organic layer was extracted with 10% aq. Na2CO3 (1 x 50 mL), sat. aq. NaCl (1 
x 20 mL), dried over Na2SO4, filtered and the solvents removed by evaporation.  Flash 
chromatography on silica gel with methanol/ethyl acetate containing 0.1% triethylamine 
provided thiazole N-oxide phosphoramidite 11 as a white foam from diethyl ether in 67% yield 
(100 mg).  Mixture of two diastereomers, Rf=0.49, 0.53 (10% MeOH:EtOAc); 1H NMR (250 
MHz, CDCl3) δ 7.66 (d, 1H, J=4.1), 7.32 (m, 12H), 6.86 (m, 4H), 5.65 (dd, 1H, J=6.0, 3.5), 4.54 
(m, 1H), 4.24 (m, 1H), 3.81 (s, 6H), 3.61 (m, 3H), 3.38 (s, 1H), 3.17 (m, 1H), 2.93 (m, 1H) 2.67 
(t, 1H, J=6.3), 2.44 (t, 1H, J=6.3), 2.19 (m, 1H), 1.10 (m, 12H);  31P NMR (101.2 MHz, CDCl3) 
δ 149.2, 148.6;  FAB(+)HRMS calcd for C8H12NO4S (M)+ 720.2889, found 720.2875 
5.1.4.11  Deprotection of DNA 
On a small scale approximately 10% of the column material was taken from the cartridge 
and treated with 50 mM K2CO3 (100 µL) for 3 h.  1.5 eq. of acetic acid in water was added to 
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quench.  The solvent was removed, avoiding the solid support, and evaporated to dryness.   
HPLC purification was performed using either a Hydrocell NS 1000 (anion-exchange) column 
(150 x 4.6 mm column) with Solvent A = 25 mM CHES pH 8, 30% methanol and Solvent B = 
25 mM CHES, 1 M (NH4)2SO4, pH 8, 30% methanol (0-100% B in 60 min with a flow rate = 1 
mL/min) or a DNAPac-100 (anion-exchange) column with Solvent A = 1 M NaCl, 25 mM 
NaOH (pH 12.4) and Solvent B = 25 mM NaOH (pH 12.4) (100-500 mM NaCl in 2 min, 500-
900 mM NaCl in 18 min, and 900-1000 mM NaCl in 3 min with a flow rate = 6 mL/min).   
5.1.5  Computational Analysis of Thiazole and Thiazole N-oxide Analogs 
5.1.5.1 Semi-empirical Analysis 
Bases with a hydrogen atom at the sugar attachment point were drawn in Hyperchem 6.0 
(Hypercube, Inc.) and minimized with a Polak-Ribiere conjugate gradient miniminization 
technique (leaving all values as default) using the AMBER force field.  Semiempircal PM3 
calculations produced the QSAR properties of surface area, dipole moment and polarizability 
values for each analog.   
In order to produce the electrostatic potential maps, in SYBYL MOPAC calculations at 
the PM3 level were performed and the electrostatic potential was mapped onto a Connolly 
surface using these charges. 
5.1.5.2 Molecular Dynamics Analysis 
The thiazole N-oxide nucleoside analog was built by modifying the cytidine nucleoside 
from the AMBER95dna dictionary.  The nitrogen of the N-oxide was defined as NA which is an 
sp2 nitrogen in aromatic rings with a hydrogen attached.  The oxygen of the N-oxide was defined 
as O2 which is an sp2 oxygen in anionic acids.  The sulfur was defined as S which is sulfur in 
methionine.  With these definitions a 1000 iteration minimization with Kollman charges using 
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the Amber 4.1 force field produced a structure which has an RMS value with the crystal structure 
of 0.07.  A further systematic search was performed to insure that the lowest energy 
conformation was being used.  This search produced a structure which had a slightly lower 
energy (about 2 kcal/mol) and an RMS fit with the crystal structure of 0.05.  This structure was 
merged into a B-type Dickerson dodecamer built using the AMBER95dna dictionary.  The 
modified DNA double helix structure was minimized using the Amber 4.1 force field and 
Kollman charges.  This minimized structure was used directly in the Molecular Dynamics 
simulations.  
Molecular Dynamics simulations were performed by ramping to 300 K or 400 K for 1 ps 
and then stepping down to zero.  These simulations used a 1 fs time step and constant pressure.  
SHAKE was used to constrain all hydrogens except those of the thiazole N-oxide-guanine base 
pair. 
5.1.6 Thermodynamic Analysis of Thiazole and Thiazole N-oxide Analogs 
Oligonucleotides were synthesized by cyanoethyl phosphoramidite chemistry at a 1.0 
µmol scale using phenoxyacetyl (Pac) phosphoramidites (Glen Research) on an Applied 
Biosystems 394 DNA/RNA Synthesizer using a standard 500 Å CPG column.  Coupling times 
were doubled for the incorporation of thiazole and thiazole N-oxide analog phosphoramidites.  
Oligonucleotides were purified by anion exchange HPLC using a Hydrocell NS 1000 (anion 
exchange) 150 x 4.6 mm column. Solvent A was 25 mM CHES pH 8, 30% MeOH while Solvent 
B was 25 mM CHES/ 1 M (NH4)2SO4 pH 8, 30% MeOH. The program consisted of ramping 0-
100% B over 60 min and the flow rate = 1 mL/min. 
Samples were prepared at multiple concentrations in degassed 1X buffer (1 M NaCl, 1 
mM EDTA, 10 mM Na2PO4).  The path lengths of the cells used for analysis ranged from 0.01 
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cm to 1 cm.  The samples were heated to 95  ºC for 2 min to drive the strands to full separation.  
They were then cooled to 5 ºC for 5 min to ensure full duplex formation.  The temperature was 
then ramped from 5 ºC to 95 ºC in 0.5 ºC increments.  Absorbance readings were recorded at 
each increment at 260 nm by a Gilford Response II UV/Vis Spectrophotometer equipped with a 
Peltier temperature controlling device and thermal software.  Following the melt, absorbance 
readings were taken at 5 ºC to ensure that evaporation did not take place during the melt. 
Extinction coefficients for the modified nucleosides were measured at 260 nm (4.97x10-4 
M for thiazole and 9.2x10-8 M for thiazole N-oxide).  These values were then used to determine 
the extinction coefficient of the DNA strand by the nearest neighbor estimate using the straight 
sum method.5.3,5.4 
Tm, ∆H, ∆S, and ∆G were obtained for each sample using Meltwin© provided by Jeffrey 
McDowell which fits a curve to the raw data points.5.5  Van’t Hoff analysis of three or more 
concentrations was performed to obtain the thermodynamic values presented. 
5.1.7 DNA Polymerase Recognition of Thiazole and Thiazole N-oxide Analogs 
Templates and primers were synthesized by cyanoethyl phosphoramidite chemistry at a 
1.0 µmol scale using phenoxyacetyl (Pac) phosphoramidites (Glen Research) on an Applied 
Biosystems 394 DNA/RNA Synthesizer using a standard 500 Å CPG column.  Coupling times 
were doubled for the incorporation of thiazole and thiazole N-oxide analog phosphoramidites.   
 Oligonucleotides containing thiazole were purified by electrophoresis on a 20% 
polyacrylamide/7 M urea gel while those containing thiazole N-oxide were purified by HPLC.  
The bands of the electrophoresis gel were visualized by UV shadowing, excised from the gel, 
and eluted overnight at 37 ºC in a 1X elution buffer (0.1% SDS, 0.5 M ammonium acetate, and 
10 mM magnesium acetate OR 0.5 M NaCl, 5 mM EDTA, pH 8.0).  The eluant was purified 
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with a C18 Sep Pak (Waters).  The oligonucleotides containing thiazole N-oxide were purified on 
a quaternary ammonium functionalized polymeric anion exchange column purchased from 
Dionex Corp, the DNAPac PA-100 column. using Buffer A (1 M NaCl, 25 mM NaOH pH 12.4) 
and Buffer B (25 mM NaOH pH 12.4).  The program consisted of ramping from 100-500 mM 
NaCl in 2 min, 500-900 mM NaCl in 18 min, and 900-1000 mM NaCl in 3 min and the flow rate 
= 6 mL/min.   The fractions were collected and desalted using a C18 Sep Pak (Waters) and 
analyzed by MALDI.  Finally, the oligonucleotides were quantified by UV absorbance at 260 
nm. 
 Primers were 5´-end 33P-labeled using T4 Polynucleotide Kinase (New England Biolabs) 
(20 U/2 nmol primer) and (γ-33P)ATP (Amersham) (250 µCi/2 nmol primer) and purity analyzed 
by electrophoresis on a 12% polyacrylamide/ 7 M urea analytical gel. 
 Extension reactions were performed in 20 µL with 200 nM radiolabeled primer and 
template, and 200 µM solution of all four dNTPs, polymerase and the supplied buffer. The 
following polymerases and buffers were used: 
(a) 5 U Taq DNA polymerase with supplied 10X Reaction Buffer (100 mM KCl, 100 mM 
(NH4)2SO4, 200 mM Tris-HCl, 20 mM MgSO4, 1% Triton X-100 pH 8.8) (New England 
Biolabs).  An additional 8 mM MgCl2 was added to the reaction. 
(b) 5 U Klenow fragment (exo-) DNA polymerase with supplied 10X Reaction Buffer (100 
mM Tris-HCl pH 7.5, 5 mM MgCl2, 7.5 mM dithiothrietol) (New England Biolabs) 
Extension reactions were stopped at the appropriate time by the addition of 20 µL gel loading 
buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol FF) 
and the products elecrophoresed on a 12% polyacrylamide/7 M urea analytical polyacrylamide 
gel.  After drying for 2 h at 80 ºC the gel was imaged on a Molecular Dynamics phosphorscreen 
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imaging plate then read on a Storm 840 scanner and analyzed using Molecular Dynamics Image-
Quant software.  The electrophoresis lanes were subjected to area analysis which created an 
electropherogram based on the intensities of the imaged bands.  The area of the product peak was 
divided by the sum of the areas of the all of the peaks in the lane.  This value was multiplied by 
100 to obtain the percentage of extension. 
To analyze the kinetic incorporation of dNTPs opposite thiazole and thiazole N-oxide the 
concentration of Kf(exo-), concentrations of dNTP, and time of incorporation were optimized to 
keep the amount of extension at or below 20%.  The concentration of DNA in the assay was kept 
constant at 2.5 µM.  Table 5.1 shows these optimized values. 
Table 5.1.  Optimized parameters for kinetic incorporation analysis. 
 Kf(exo-) (U/µl) Time dNTP (µM) 
T-template 
dATP 0.005 30 s 2.5, 5, 7.5, 10, 20 µM 
dGTP 0.005 5 min 50, 75, 100,150, 200 µM 
C-template 
dATP 0.02 5 min 25, 50, 75, 100, 150 µM 
dGTP 0.005 1 min 2.5, 5, 7.5, 10, 15 µM 
Z-template 
dATP 0.01 30 s 5, 10, 15, 20, 25 µM 
dGTP 0.02 3 min 25, 50, 75, 100, 150 µM 
      
 
 
 143
 The radiolabeled primer and template were incubated in 4X reaction buffer at 95 ºC for 1 
min.  The appropriate amount of this annealing mix was then added to Solution A containing 2X 
reaction buffer, 2X BSA, and the appropriate amount of Kf(exo-).  Solution B was prepared by 
adding stock dNTP solution to 2X reaction buffer to obtain the varying dNTP concentrations.  
Solution A was incubated at 37 ºC for 2 min.  The incorporation was initiated by the addition of 
an equal volume of Solution B to Solution A and the reaction incubated at 37 ºC for the 
appropriate length of time.  Reactions were stopped by the addition of 10 µL gel loading buffer 
(95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol FF) and 
the products elecrophoresed on a 12% polyacrylamide/7 M urea analytical polyacrylamide gel.  
After drying for 2 h at 80 ºC the gel was imaged on a Molecular Dynamics phosphorscreen 
imaging plate then read on a Storm 840 scanner and analyzed using Molecular Dynamics Image-
Quant software.  The electrophoresis lanes were subjected to area analysis which created an 
electropherogram based on the intensities of the imaged bands.  The area of the product peak was 
divided by the sum of the areas of the product and primer peaks.  This value was multiplied by 
100 to obtain the percentage of extension.  The velocity of incorporation was calculated by 
dividing the percentage extension by the time in minutes.  Linear plots of dNTP concentration 
divided by velocity versus dNTP concentration (Hanes-Wolf plots) were obtained using 
Microsoft Excel 2000.  Km and Vmax values were then calculated from the slope and y-intercept 
values. 
5.2    Nucleoside Backbone Analogs-Chapter 3 
5.2.1 Synthesis of N3´→P5´ Phosphoramidate Backbone Modification 
The 5´-O-DMT-2´,3´-dideoxy-3´-aminothymidine was synthesized as previously reported 
and then was used in a modified synthetic cycle for the automated synthesis of the primer used in 
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the extension reactions at a 1.0 µmol scale on an Applied Biosystems 394 DNA/RNA 
Synthesizer using a standard 500 Å CPG column.5.6-11   
5.2.2 Exonuclease Resistance Assays 
Templates and primers containing only phosphodiester linkages were synthesized by 
cyanoethyl phosphoramidite chemistry at a 1.0 µmol scale on an Applied Biosystems 394 
DNA/RNA Synthesizer using a standard 500 Å CPG column.  For synthesis of the primer 
containing a 3´-phosphorothioate linkage standard cyanoethyl phosphoramidite chemistry was 
used with an additional sulferization step utilizing 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) 
after the first phosphoramidite coupling.  This primer was also synthesized at a 1.0 µmol scale on 
an Applied Biosystems 394 DNA/RNA Synthesizer using a standard 500 Å CPG column.  All 
oligonucleotides were purified by electrophoresis on a 19% polyacrylamide/7 M urea gel.  The 
bands were visualized by UV shadowing, excised from the gel, and eluted overnight at 37 ºC in a 
1X elution buffer (0.1% SDS, 0.5 M ammonium acetate, and 10 mM magnesium acetate).  The 
eluant was purified with a C18 Sep Pak (Waters).  Finally, the oligonucleotides were quantified 
by UV absorbance at 260 nm. 
 Primers were 5´-end 33P-labeled using T4 Polynucleotide Kinase (New England Biolabs) 
(5 U/4 pmol) and (γ-33P)ATP (Amersham) (12 µCi/4 pmol)  and purity analyzed by 
electrophoresis on an 8% polyacrylamide/ 7 M urea analytical gel. 
 Extension reactions were performed with 20 pM primer, 50 pM template, and 200 µM 
solution of all four dNTPs, polymerase and the supplied buffer. The following polymerases and 
buffers were used: 
(a) 2.5 U AmpliTaq® DNA polymerase with supplied 10X Reaction Buffer (100 mM 
Tris-HCl pH 8.3, 500 mM KCl) (Perkin-Elmer) 
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(b) 1 U Vent(exo+) DNA polymerase with supplied 10X Reaction Buffer (100 mM KCl, 
100 mM (NH4)2SO4, 20 mM Tris-HCl pH 8.8, 20 mM MgSO4, 1% Triton X-100) (New 
England Biolabs) 
(c) 1.75 U Pfu(exo+) DNA polymerase with supplied 10X Reaction Buffer (200 mM 
Tris-HCl (pH 8.8), 100 mM KCL, 100 mM (NH4)2SO4, 20 mM MgSO4, 1% Triton X-
100, 1mg/mL nuclease free bovine serum albumin (BSA)) (Stratagene) 
 Extension reactions were then subjected to restriction endonuclease digests.  Extension of 
the template with a 3´-match base pair was digested with 10 U BslI restriction endonuclease 
(New England Biolabs) (supplied 10X reaction buffer: 1 M NaCl, 500 mM Tris-HCl, 100 mM 
MgCl2, 1 mM DTT, pH 7.9) at 55 ºC for 60 min.  Extension of the template with a 3´-mismatch 
base pair was digested with 1 U TaqαI restriction endonuclease (New England Biolabs)(supplied 
10X reaction buffer: 1 M NaCl, 100 mM Tris-HCl, 100 mM MgCl2, pH 8.4)) at 65 ºC for 60 
min.  Reactions were stopped by the addition of 4 µl gel loading buffer (95% formamide, 20 mM 
EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol FF) and the products 
electrophoresed on an 8% polyacrylamide/7 M urea analytical polyacrylamide gel.  After drying 
for 2 h at 80 ºC the gel was imaged on a Molecular Dynamics phosphorscreen imaging plate then 
read on a Storm 840 scanner and analyzed using Molecular Dynamics Image-Quant software.  
The electrophoresis lanes were subjected to area analysis which created an electropherogram 
based on the intensities of the imaged bands.  The area of the product peak was divided by the 
sum of the areas of the product and primer peaks.  This value was multiplied by 100 to obtain the 
percentage of extension. 
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5.2.3 Kinetic Exonuclease Resistance Assays 
Primers were 5´-end 33P-labeled as stated above.  The reactions were mixed as an extension 
reaction.  Only Vent and Pfu polymerases were used in the above buffers.  Aliquots of the 
reactions were removed and stopped at t = 0, 10 s, 30 s, 1 min, 5 min, 10 min, 30 min, and 1 h.  
The reactions were stopped with gel loading buffer (95% formamide, 20 mM EDTA, 0.05% 
bromophenol blue, and 0.05% xylene cyanol FF) and cooled on ice (0 ºC).  The aliquots were 
analyzed by electrophoresis on an 8% polyacrylamide/7 M urea analytical polyacrylamide gel.  
After drying for 2 h at 80 ºC the gel was imaged on a Molecular Dynamics phosphorscreen 
imaging plate then read on a Storm 840 scanner and analyzed using Molecular Dynamics Image-
Quant software.   
5.3    Capillary and Microdevice Electrophoresis of LDR-Chapter 4 
5.3.1 DNA sample preparation 
All LDR primers and model sample oligonucleotides were purchased from Integrated 
DNA Technologies (IDT, Coralville, IA) with PAGE purification and 5´-fluorescein labeling of 
LDR discriminating primers and model sample oligonucleotides.  Model samples were prepared 
in 1:10, 1:100, and 1:1000 molar ratios of 44nt and 51nt oligonucleotides to 25nt 
oligonucleotide.  The 25nt was 1 µM and the 44nt and 51nt were 100 nM, 10 nM, and 1 nM for 
the 1:10, 1:100, and 1:1000 samples, respectively. 
5.3.2 LDR Conditions 
PCR products from the amplification of exon 1 of the K-ras gene were obtained from the 
laboratory of Dr. Francis Barany and used as templates in LDR reactions as described 
elsewhere.5.12,5.13  Briefly, the reactions were performed in a final volume of 20 µL.  500 nM of 
each discriminating primer  and the appropriate amount of mutant and wild type templates for 
 147
the ratio being tested were used and ligated with Tth ligase (1 nM) in a 1X reaction buffer (10 
mM Tris-HCl pH 7.6, 10 mM MgCl2, 0.1 M KCl, and 20 µg/mL bovine serum albumin) as well 
as 10 mM dithiothreitol and 1.25 mM NAD+ (nicotinic adenine dinucleotide, a cofactor of Tth 
ligase).  The reaction mixtures without the ligase were heated to 94 ºC for 1.5 min.  The ligase 
was then added to the reaction and the reaction cycled 20 times at 94 ºC for 15 s and 65 ºC for 4 
min.  Reactions were stopped by the addition of 0.5 µL of 0.5 mM EDTA in an ethanol-dry ice 
bath.  Reactions were desalted on a C18 Sep Pak (Waters) before electrophoretic analysis.  
5.3.3 Instrumentation-CE 
The POP5 Performance Optimized Polymers were obtained from PE Biosystems (Foster 
City, PA).  A capillary (75 µM i.d., 50 cm effective length, 56 cm total length) was filled at 
approximately 1000 psi before each analysis.  The optimized run voltage was 12 kV while the 
capillary temperature was controlled at 50 ºC.  The eCap ssDNA 100-R Gel, buffer, and 
neutrally coated capillary (75 µM i.d.) were purchased from Beckman Coulter (Fullerton, CA).  
A capillary (30 cm effective length, 36 cm total length) was filled at approximately 800 psi and 
was used for 5 separations at 308 V/cm at 30 ºC.  The µPAGE-5 (5%T, 5%C) polyacrylamide 
gel-filled capillary and buffer were purchased from Agilent Technologies (Palo Alto, CA).  The 
capillary length was 56 cm while the effective length was 50 cm.  Injection was typically at 10 
kV for 10 s and separation at 250 V at 25  ºC.   
Separations were performed using a Beckman P/ACE CE fitted with an LIF module 
containing an Argon ion laser (excitation at 488 nm) and a 510 nm emission filter. 
5.3.4 Instrumentation-Microdevice 
The microdevices, LIF detection system, and switch box were all designed in-house as 
described earlier.5.14  The microdevice was manually filled with POP5 matrix then the injection, 
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waste, and buffer reservoirs were flushed with buffer.  The buffer was removed from the sample 
well and the sample added just prior to analysis.  Injection was typically at 500 V for 5 s and 
separation was at 3.5 kV.  Pullback voltages on the sample and waste wells during separation 
were 500 and 300 V, respectively. 
5.4    References 
5.1 Saurage, A. S. Synthesis, Thermodynamic Stability and Enzymic Behavior of 
Oligonucleotides Containing Pyrazole Nucleobase Analogs. In Department of Chemistry; 
Louisiana State University: Baton Rouge, 1999; pp 99. 
 
5.2 Miller, T. J.; Farquar, H. D.; Sheybani, A.; Tallini, C. E.; Saurage, A. S. et al. Synthesis 
of oligonucleotides containing thiazole and thiazole N-oxide nucleobases. Organic 
Letters 2002, 4, 877-880. 
 
5.3 Warshaw, M. M.; Tinoco, I. J. Mol. Biol. 1966, 26, 29. 
 
5.4 Cantor, C. R.; Warshaw, M. M.; Shapiro, H. Oligonucleotide Interactions 3. Circular 
Dichroism Studies of Conformation of Deoxyoligonucleotides. Biopolymers 1970, 9, 
1059. 
 
5.5 McDowell, J. A.; Turner, D. H. Investigation of the structural basis for thermodynamic 
stabilities of tandem GU mismatches: Solution structure of (rGAGGUCUC)(2) by two-
dimensional NMR and simulated annealing. Biochemistry 1996, 35, 14077-14089. 
 
5.6 Luo, J. Y.; Barany, F. Identification of essential residues in Thermus thermophilus DNA 
ligase. Nucleic Acids Research 1996, 24, 3079-3085. 
 
5.7 Luo, J. Y.; Bergstrom, D. E.; Barany, F. Improving the fidelity of Thermus thermophilus 
DNA ligase. Nucleic Acids Research 1996, 24, 3071-3078. 
 
5.8 Chen, J. K.; Schultz, R. G.; Lloyd, D. H.; Gryaznov, S. M. Synthesis of 
Oligodeoxyribonucleotide N3'-]P5' Phosphoramidates. Nucleic Acids Research 1995, 23, 
2661-2668. 
 
5.9 Gryaznov, S. M.; Letsinger, R. L. Synthesis and Properties of Oligonucleotides 
Containing Aminodeoxythymidine Units. Nucleic Acids Research 1992, 20, 3403-3409. 
 
5.10 Gryaznov, S.; Chen, J. K. Oligodeoxyribonucleotide N3'->P5' Phosphoramidates - 
Synthesis and Hybridization Properties. Journal of the American Chemical Society 1994, 
116, 3143-3144. 
 
 149
5.11 Baraniak, J.; Korczynski, D.; Kaczmarek, R.; Wasilewska, E. New approach to the solid 
phase synthesis of N3'->P5' phosphoramidate oligonucleotides. Nucleosides & 
Nucleotides 1998, 17, 1347-1353. 
 
5.12 Barany, F. Genetic-Disease Detection and DNA Amplification Using Cloned 
Thermostable Ligase. Proceedings of the National Academy of Sciences of the United 
States of America 1991, 88, 189-193. 
 
5.13 Khanna, M.; Park, P.; Zirvi, M.; Cao, W. G.; Picon, A. et al. Multiplex PCR/LDR for 
detection of K-ras mutations in primary colon tumors. Oncogene 1999, 18, 27-38. 
 
5.14 Thomas, G. A. Capillary and Microdevice Electrophoretic Tools for Genetic Analyses:  
Heteroduplex Analysis for Tuberculosis Drug Susceptibility and Ligase Detection 
Reaction for Colorectal Cancer Detection. In Department of Chemistry; Louisiana State 
University: Baton Rouge, 2001; pp 130. 
 150
Appendix: Thermal Melting Raw Data and MALDI Mass Spectra 
 
Contained in the following pages is the raw data for the thermodynamic analysis of the 
Dickerson dodecamer containing thiazole and thiazole N-oxide nucleoside analogs and 
well as MALDI mass spectrum of the Dickerson dodecamer as well as 28nt 
oligonucleotide synthesized containing thiazole and thiazole N-oxide analog.  The 
thermodynamic values of Tm, ∆H, ∆S, and ∆G were calculated by the program Meltwin® 
for each melt curve shown.  From the Tm plots of 1/Tm versus ln(C) are obtained in a 
Van’t Hoff analysis giving averaged values of ∆H, ∆S, and ∆G. 
 
C-G Dickerson Dodecamer:    5´-CGCCAATTGCGC-3´ 
     3´-GCGGTTAACGCG-5´ 
 
 
Van’t Hoff Analysis: 
∆H = -55.43 kcal/mol 
∆S = -144.16 cal/K·mol 
∆G = -10.72 kcal/mol 
Tm = 67.9 ºC 
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Melt Curve 5.17E-06M
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Melt Curve 1.30E-04M
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Melt Curve 8.96E-04M
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T-A Dickerson Dodecamer:    5´-CGCAAATTTCGC-3´ 
     3´-GCGTTTAAAGCG-5´ 
 
 
Van’t Hoff Analysis: 
∆H = -79.92  kcal/mol 
∆S = -216.87 cal/K·mol 
∆G = -12.65  kcal/mol 
Tm = 67.1 ºC 
 
 
1/Tm vs ln(C)
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Melt Curve 1.010E-05
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Melt Curve 1.580E-05
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Melt Curve 7.170E-05
b = 0.1; ∆H = -72.54; ∆S = -196.41; ∆G = -11.63 
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Melt Curve 6.350E-04
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Melt Curve 7.590E-04
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Z-A Dickerson Dodecamer:     5´-CGCZAATTACGC-3´ 
     3´-GCGATTAAZGCG-5´ 
 
Van’t Hoff Analysis: 
∆H = -35.79  kcal/mol 
∆S = -107.01 cal/K·mol 
∆G = -2.60  kcal/mol 
Tm = 11.5  ºC 
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Melt Curve 6.590E-05
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Melt Curve 1.317E-03
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Z-G Dickerson Dodecamer:     5´-CGCZAATTGCGC-3´ 
     3´-GCGGTTAAZGCG-5´ 
 
 
Van’t Hoff Analysis: 
∆H = -53.18  kcal/mol 
∆S = -164.74 cal/K·mol 
∆G = -2.08  kcal/mol 
Tm = 16.5  ºC 
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Melt Curve 1.856E-05
b = 0.5; ∆H = -23.19; ∆S = -59.28; ∆G = -4.81 
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Melt Curve 9.514E-05
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Melt Curve 7.128E-04
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X-A Dickerson Dodecamer:     5´-CGCXAATTACGC-3´ 
     3´-GCGATTAAXGCG-5´ 
 
 
Van’t Hoff Analysis: 
 
Tm = <0 
 
 
Melt Curve 4.520E-04
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Melt Curve 9.170E-04
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X-G Dickerson Dodecamer:    5´-CGCXAATTGCGC-3´ 
     3´-GCGGTTAAXGCG-5´ 
 
 
Van’t Hoff Analysis: 
∆H = -141.74  kcal/mol 
∆S = -442.97 cal/K·mol 
∆G = -4.35  kcal/mol 
Tm = 26.6  ºC 
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Melt Curve 8.190E-04
b = 0.02; ∆H = -43.63; ∆S = -126.71; ∆G = -4.33
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Melt Curve 1.890E-03
b = 0.01; ∆H = -41.68; ∆S = -121.45; ∆G = -4.01
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Melt Curve 4.036E-04
b = 0.02; ∆H = -29.03; ∆S = -78.38; ∆G = -4.72
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MALDI mass spectrum of 5'-CGCThAATTTGCG-3'  
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MALDI mass spectrum of 5'-CGCThAATTTGCG'  
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MALDI mass spectrum of 5'-CGCOxAATTTGCG-3' 
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MALDI mass spectrum of 5'-AATTTGCG-3' 
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MALDI mass spectrum of 5´- ACTGThTCTCCCTATAGTGAGTCGTATTA-3´ 
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MALDI mass spectrum of 5´- ACTGOxTCTCCCTATAGTGAGTCGTATTA-3´ 
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MALDI mass spectrum of 5´- TCTCCCTATAGTGAGTCGTATTA-3´ 
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